Oncology Books
Springer Nature Switzerland AG Cancer Metastasis Through the Lymphovascular
Book SynopsisThis textbook describes in detail the process of cancer metastasis from a single cell in the primary site through its arduous journey to the sentinel lymph node as the main gateway and beyond to distant sites. The most up-to-date knowledge on key topics in the molecular biology, diagnosis, and treatment of metastatic cancer is highlighted by a large panel of experts. The book begins with a comprehensive overview of the genetic and molecular mechanisms that promote or inhibit cancer metastasis through lymphatic pathways to lymph nodes or through vascular pathways to distant sites, providing the reader with an essential basic knowledge. This is followed by further details on the role of the immune system within the primary tumor and the lymph node and the importance of the microenvironment at the metastatic site. The role of the sentinel lymph node in cancer metastasis is emphasized. Special attention is also given to state-of-the-art imaging techniques for the detection of early-stage cancer and cancer metastases, as well as the use of liquid biopsies in sarcoma, prostate, gastrointestinal, and lung cancer. Clinical patterns of malignant tumors arising in different organ systems are compared, described, and discussed with the goal of determining what similarities and/or differences exist. The book concludes with a detailed discussion of surgical intervention, radiation, and systemic therapy of primary and metastatic cancer, and briefly previews several emerging topics, such as the latest findings on personalized cancer therapy, cancer stem cells, unique molecular mechanisms of virus-induced cancer, the impact of the microbiome on cancer metastasis and the application of artificial intelligence in cancer metastasis research. By providing fundamental knowledge of the biological and clinical aspects of cancer metastasis, this book will be an important reference for cancer researchers, clinical oncologists, teachers, and students. Written by experts in the field, each chapter includes a summary of the chapter's key points and open-ended questions that address pressing issues in the field and encourage the reader to consider future directions. Table of Contents
£123.49
Springer Nature Switzerland AG Clinical Cases in Pediatric Skin Cancers
Book SynopsisThis book is a concise practical guide designed to facilitate the clinical decision-making process in the management of pediatric skin cancers. Dermatologists, oncologists and general pediatricians who offer primary care to children must be knowledgeable in identifying and managing dermatological cancers, and this title provides insightful reviews of a number of common and rare dermatologic cases. Clinical cases are a key component in modern medical education, assisting the trainee or recertifying clinician to work through unusual scenarios using best practice techniques. Pediatric dermatology is a particularly important discipline in this regard since it is a highly visual subject requiring the reader to describe often very subtle differences in the presentation of patients and define accurately the diagnostic and management criteria on which to base their clinical decision-making. Clinical Cases in Pediatric Skin Cancers concisely covers how to approach diagnosing and managing skin cancers in pediatric patients. Each chapter focuses on a particular case and emphasizes how to make an appropriate choice when deciding which diagnostic tool or management strategy would be most suitable. Potential complications are detailed and management tips provided to enable the reader to develop a deep understanding of how approach the care of these patients within their day-to-day clinical practice. This book therefore represents an ideal up-to-date resource for all practitioners who encounter these cases as part of their everyday practice.Table of Contents20-30 cases/chapters of 4-6 pages (=c. 2500 words) that cover the discipline in a structured fashion and covering all aspects of the topicChapters will include the following:Conventional melanoma Spitzoid melanomaCongenital melanocytic nevus MelanomaBasal Cell CarcinomasSquamous Cell Carcinomas Benign skin neoplasmsGenetic skin neoplasmsVirus induced skin neoplasms in children
£999.99
Springer Nature Switzerland AG Target Volume Delineation and Field Setup: A
Book SynopsisThis practical guide, now in a revised and updated second edition with more clinical cases for different stages, is designed as a concise reference on the delineation of target volumes in radiation oncology. Clear guidance is provided on simulation, setup, and field design for all of the malignancies commonly encountered by practicing radiation oncologists, and slice-by-slice examples are provided for different clinical stages and scenarios. The new edition of this book fully covers modern radiotherapy field design, with inclusion of guidelines on immobilization and simulation for 3D-conformal radiotherapy, intensity-modulated radiation therapy, and stereotactic body radiation therapy. Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy is written by leading radiation oncologists who provide their expert opinions on all relevant aspects.Table of Contents1.Nasopharyngeal Cancer 2.Oropharyngeal Cancer 3. Stereotactic Body Radiotherapy for Head and Neck Cancer4. Larynx Cancer 5.Hypopharyngeal Cancer 6.Oral Cavity Cancer 7.Nasal cavity and Paranasal Sinus Cancer 8.Major Salivary Glands 9.Thyroid Cancer 10.Squamous Cell Carcinomas of Unknown Primary in the Head and Neck 11.Early Breast Cancer 12.Regional Lymph Node Irradiation for Breast Cancer 13.Lung Cancer 14.Esophageal Cancer 15.Gastric Cancer 16.Pancreatic Cancer 17.Hepatocellular Cancer 18.Rectal Cancer 19.Anal Caner 20.Postoperative Therapy for Cervical, Vaginal, and Endometrial Cancer 21.Definitive Therapy for Cervical, Vaginal, and Endometrial Cancer 22.Image-guided brachytherapy Ovarian Cancer 23.Vulvar Cancer 24.Advanced Technologies and Treatment Techniques for Gynecologic Malignancies25.Prostate Adenocarcinoma26.Bladder Cancer 27.Testicular Seminoma 28.Brain Metastases 29.Benign Tumors of the CNS30.Malignant tumors of the CNS31.Hodgkin's and Non-hodgkin's Lymphoma32.Soft Tissue Sarcoma33.Pediatric Sarcoma 34.Pediatric Brain Tumors
£999.99
Springer International Publishing AG Advances in Diagnosis and Management of Ovarian
Book SynopsisThis new edition features updated information on all aspects of the diagnosis and management of ovarian cancer. Embracing knowledge from around the world, this multidisciplinary book discusses current approaches to ovarian cancer that have helped stabilize the rate of both incidences and fatality for the disease. The chapters focus on genetic screening and advances in management, including the optimization of chemotherapeutic agents, gene therapy, and the latest laparoscopic and robotic surgical techniques. Further chapters address psychosocial and quality-of-life issues as well. The book is a must-have resource for wide range of practitioners who care for patients with ovarian cancer and researchers who study the disease.Table of Contents1. Ovarian Cancer Epidemiology2. Ovarian Cancer Screening and Early Detection 3. Ovarian Cancer Biomarkers 4. Hereditary Ovarian Cancer 5. Ovarian Cancer Pathology 6. Current Management of Patients with Early- stage Ovarian Cancer 7. Treatment of Advanced Stage Ovarian Cancer 8. Management of Recurrent Ovarian Cancer 9. Overview of Ovarian Cancer Chemotherapy. 10. Management of Epithelial Ovarian Cancer with Peritoneal Metastases 11. Targeted Molecular Therapy for Ovarian Cancer Patients 12. Ovarian Cancer in the Pediatric Population 13. Quality of Life in Women with Ovarian Cancer
£116.99
Springer International Publishing AG Advancing the Science of Cancer in Latinos:
Book SynopsisThis open access book is a collection of articles based on presentations from the 2020 Advancing the Science of Cancer in Latinos conference that gives an overview of conference outcomes. The vision of the conference has been to unite researchers, scientists, physicians and other healthcare professionals, patient advocates, and students from across the world to discuss research advancements, identify gaps, and develop actionable goals to translate basic research findings into clinical best practices, effective community interventions, and professional training programs to decrease cancer risks and eliminate cancer disparities for Latinos. This conference comes at an especially important time when Latinos – the largest and youngest minority group in the U.S. – are expected to face a 142% rise in cancer cases in the coming years. Disparities continue to impact this population in critical areas: access to preventive and clinical care, changeable risk behaviors, quality of life, and mortality. Each chapter summarizes the presentation and includes current knowledge in the specific topic areas, identified gaps, and opportunities for future research. Topics explored include: Applying an Exposome-Wide (ExWAS) Approach to Latino Cancer Disparities Supportive Care Needs and Coping Strategies Used by Latino Men Cancer Survivors Optimizing Engagement of the Latino Community in Cancer Research Latino Population Growth and the Changing Demography of Cancer Implementation Science to Enhance the Value of Cancer Research in Latinos A Strength-Based Approach to Cancer Prevention in Latinxs Overcoming Clinical Research Disparities by Advancing Inclusive Research Advancing the Science of Cancer in Latinos: Building Collaboration for Action will appeal to a wide readership due to its comprehensive coverage of topics ranging from basic science and community prevention research to clinical practice to policy. The book is an essential resource for physicians and other medical professionals, researchers, scientists, academicians, patient advocates, and students. It also will appeal to policy-makers, NCI-designated cancer centers, academic centers, state health departments, and community organizations.Table of ContentsPart I Introduction 1..... Advancing the Science of Cancer in Latinos Amelie G. Ramirez, Edward J. Trapido Part II Health Threats in the Latino Community 2..... Applying an Exposome-Wide (ExWAS) Approach to Latino Cancer Disparities Paul D. Juarez, Darryl Hood, Min-ae Song, Aramandla Ramesh 3..... Population Health Challenges for Latinos in the US Alexander N. Ortega Part III Vulnerable Populations and Cancer Health Disparities 4..... Acute and Long-Term Neurological Complications of Acute Lymphoblastic Leukemia (ALL) Therapy in Latino Children Austin L. Brown, Kimberly P. Raghubar, Michael E. Scheurer, Philip J. Lupo Part IV Cancer Outcomes and Survivorship in Latinos 5..... Supportive Care Needs and Coping Strategies Used by Latino Men Cancer Survivors Dinorah Martinez-Tyson, Erik L. Ruiz 6..... Cancer Care Delivery Among Breast Cancer Patients: Is It the Same for All? Catalina Malinowski, Mariana Chavez-MacGregor Part V Cancer in the Era of Precision Medicine 7..... Genetic Ancestry and Breast Cancer Subtypes in Hispanic/Latina Women Lizeth I. Tamayo, Elam Day-Friedland, Valentina A. Zavala, Katie M. Marker, Laura Fejerman 8..... Precision Medicine Approaches for Stratification and Development of Novel Therapies of Latin(x) Patients at Risk of Lung Malignancy Kenneth S. Ramos, Stefano Guerra, Randa El-zein Part VI Engaging Latinos in Cancer Research 9..... Optimizing Engagement of the Latino Community in Cancer Research Lourdes Baezconde-Garbanati, Bibiana Martinez, Carol Ochoa, Sheila Murphy, Rosa Barahona, Carolina Aristizabal, Yaneth L. Rodriguez Part VII Emerging Policies Impacting Latino Care 10.... Latino Population Growth and the Changing Demography of Cancer Rogelio Sáenz 11.... Financial Hardship, Food Insecurity, and Forgone Medical Care Jean A. McDougall, Shoshana Adler Jaffe, Dolores D. Guest, V. Shane Pankratz, Charles L. Wiggins, Angela L. W. Meisner, Andrew L. Sussman Part VIII Implementation Science, Innovative Technologies and the Future of Cancer Care 12.... Implementation Science to Enhance the Value of Cancer Research in Latinos: A Perspective from the National Cancer Institute Gila Neta 13.... Advancing E-health Interventions in Cancer Control and Survivorship for Hispanic/Latina Breast Cancer Patients Sharon H. Baik, Joanna Buscemi, Laura B. Oswald, Diana Buitrago, Judith Guitelman, Francisco Iacobelli, Melissa A. Simon, Frank J. Penedo, Betina Yanez Part IX Latino Lifestyles: Acculturation, Nutrition, and Health 14.... Impact of Obesity and Related Factors in Breast Cancer Survivorship Among Hispanic Women Elisa V. Bandera, Chi-Chen Hong, Bo Qin 15.... A Strength-Based Approach to Cancer Prevention in Latinxs Marisa S. Torrez-Ruiz, Sandra Soto, Nanette V. Lopez, Elva M. Arredondo Part X Advances in Cancer Therapy and Clinical Trials 16.... Overcoming Clinical Research Disparities by Advancing Inclusive Research Melissa Gonzales Part XI HPV Vaccination for Cancer Prevention 17.... The Road to Cervical Cancer Elimination Anna R. Giuliano Part XII Latino Cancer Health Disparities: Moving Forward 18.... Looking Forward: Continuing the Collaboration for Action Amelie G. Ramirez, Edward J. Trapido Appendix A: Advances in Biology and Treatment of Cancer Appendix B: Cancer Epidemiology and Prevention Appendix C: Engaging Latinos in Research Across the Cancer Continuum Appendix D: Living with and Beyond Cancer: Taking Action to Improve Outcomes
£999.99
Springer International Publishing AG Advancing the Science of Cancer in Latinos:
Book SynopsisThis open access book is a collection of articles based on presentations from the 2020 Advancing the Science of Cancer in Latinos conference that gives an overview of conference outcomes. The vision of the conference has been to unite researchers, scientists, physicians and other healthcare professionals, patient advocates, and students from across the world to discuss research advancements, identify gaps, and develop actionable goals to translate basic research findings into clinical best practices, effective community interventions, and professional training programs to decrease cancer risks and eliminate cancer disparities for Latinos. This conference comes at an especially important time when Latinos – the largest and youngest minority group in the U.S. – are expected to face a 142% rise in cancer cases in the coming years. Disparities continue to impact this population in critical areas: access to preventive and clinical care, changeable risk behaviors, quality of life, and mortality. Each chapter summarizes the presentation and includes current knowledge in the specific topic areas, identified gaps, and opportunities for future research. Topics explored include: Applying an Exposome-Wide (ExWAS) Approach to Latino Cancer Disparities Supportive Care Needs and Coping Strategies Used by Latino Men Cancer Survivors Optimizing Engagement of the Latino Community in Cancer Research Latino Population Growth and the Changing Demography of Cancer Implementation Science to Enhance the Value of Cancer Research in Latinos A Strength-Based Approach to Cancer Prevention in Latinxs Overcoming Clinical Research Disparities by Advancing Inclusive Research Advancing the Science of Cancer in Latinos: Building Collaboration for Action will appeal to a wide readership due to its comprehensive coverage of topics ranging from basic science and community prevention research to clinical practice to policy. The book is an essential resource for physicians and other medical professionals, researchers, scientists, academicians, patient advocates, and students. It also will appeal to policy-makers, NCI-designated cancer centers, academic centers, state health departments, and community organizations.Table of ContentsPart I Introduction 1..... Advancing the Science of Cancer in Latinos Amelie G. Ramirez, Edward J. Trapido Part II Health Threats in the Latino Community 2..... Applying an Exposome-Wide (ExWAS) Approach to Latino Cancer Disparities Paul D. Juarez, Darryl Hood, Min-ae Song, Aramandla Ramesh 3..... Population Health Challenges for Latinos in the US Alexander N. Ortega Part III Vulnerable Populations and Cancer Health Disparities 4..... Acute and Long-Term Neurological Complications of Acute Lymphoblastic Leukemia (ALL) Therapy in Latino Children Austin L. Brown, Kimberly P. Raghubar, Michael E. Scheurer, Philip J. Lupo Part IV Cancer Outcomes and Survivorship in Latinos 5..... Supportive Care Needs and Coping Strategies Used by Latino Men Cancer Survivors Dinorah Martinez-Tyson, Erik L. Ruiz 6..... Cancer Care Delivery Among Breast Cancer Patients: Is It the Same for All? Catalina Malinowski, Mariana Chavez-MacGregor Part V Cancer in the Era of Precision Medicine 7..... Genetic Ancestry and Breast Cancer Subtypes in Hispanic/Latina Women Lizeth I. Tamayo, Elam Day-Friedland, Valentina A. Zavala, Katie M. Marker, Laura Fejerman 8..... Precision Medicine Approaches for Stratification and Development of Novel Therapies of Latin(x) Patients at Risk of Lung Malignancy Kenneth S. Ramos, Stefano Guerra, Randa El-zein Part VI Engaging Latinos in Cancer Research 9..... Optimizing Engagement of the Latino Community in Cancer Research Lourdes Baezconde-Garbanati, Bibiana Martinez, Carol Ochoa, Sheila Murphy, Rosa Barahona, Carolina Aristizabal, Yaneth L. Rodriguez Part VII Emerging Policies Impacting Latino Care 10.... Latino Population Growth and the Changing Demography of Cancer Rogelio Sáenz 11.... Financial Hardship, Food Insecurity, and Forgone Medical Care Jean A. McDougall, Shoshana Adler Jaffe, Dolores D. Guest, V. Shane Pankratz, Charles L. Wiggins, Angela L. W. Meisner, Andrew L. Sussman Part VIII Implementation Science, Innovative Technologies and the Future of Cancer Care 12.... Implementation Science to Enhance the Value of Cancer Research in Latinos: A Perspective from the National Cancer Institute Gila Neta 13.... Advancing E-health Interventions in Cancer Control and Survivorship for Hispanic/Latina Breast Cancer Patients Sharon H. Baik, Joanna Buscemi, Laura B. Oswald, Diana Buitrago, Judith Guitelman, Francisco Iacobelli, Melissa A. Simon, Frank J. Penedo, Betina Yanez Part IX Latino Lifestyles: Acculturation, Nutrition, and Health 14.... Impact of Obesity and Related Factors in Breast Cancer Survivorship Among Hispanic Women Elisa V. Bandera, Chi-Chen Hong, Bo Qin 15.... A Strength-Based Approach to Cancer Prevention in Latinxs Marisa S. Torrez-Ruiz, Sandra Soto, Nanette V. Lopez, Elva M. Arredondo Part X Advances in Cancer Therapy and Clinical Trials 16.... Overcoming Clinical Research Disparities by Advancing Inclusive Research Melissa Gonzales Part XI HPV Vaccination for Cancer Prevention 17.... The Road to Cervical Cancer Elimination Anna R. Giuliano Part XII Latino Cancer Health Disparities: Moving Forward 18.... Looking Forward: Continuing the Collaboration for Action Amelie G. Ramirez, Edward J. Trapido Appendix A: Advances in Biology and Treatment of Cancer Appendix B: Cancer Epidemiology and Prevention Appendix C: Engaging Latinos in Research Across the Cancer Continuum Appendix D: Living with and Beyond Cancer: Taking Action to Improve Outcomes
£999.99
Springer International Publishing AG Oncologic Surgical Emergencies: A Practical Guide
Book SynopsisThis book will offer a practical guide for the surgical management of oncologic emergencies, that pose great challenges to both surgeons and oncologists. Combining the knowledge of experienced surgeons and oncologists, it describes the experience gained from daily life into a tertiary hospital. Every chapter will be focused on radical treatment of primary tumors, metastatic disease and palliation, and will include an “Highlight” section with 4-5 key messages at the beginning of each chapter, whereas at the end a flow-diagram will be employed to summarize the subject discussed topic. Every chapter will be written by at least two authors, including a surgeon and an oncologist, to guarantee a 360 degrees analysis of each topic. This work will benefit both surgeons and oncologists: surgeons will found in it a step to step practical tool that helps the decision making process, while oncologists will find interesting indications about how and when to involve a general surgeon into the management of an oncologic emergent condition.Table of ContentsHead and neck.- Adrenal glands.- Lung.- Esophagus.- Stomach.- Duodenum.- Small Bowel.- Right colon.- Appendix.- Left colon.- Rectum.- Liver.- Pancreas.- Gallbladder and biliary tract.- Spleen.- Uterus and Ovaries.- Kidney.- Urinary Bladder.- Peritoneal carcinosis.- Miscellaneous rare malignancies - Intra-abdominal lymphomas.- Miscellaneous rare malignancies – GIST.- Miscellaneous rare malignancies – Desmoplastic.- Miscellaneous rare malignancies – Sarcomas.- Miscellaneous rare malignancies - Pseudomixoma peritoneum.- Ethical issues.
£116.99
Springer International Publishing AG Controversies in Thyroid Nodules and
Book SynopsisThis book provides a practical, evidence-based approach to controversies in the management of thyroid nodules and differentiated thyroid cancer (DTC). Thyroid nodules are a commonly encountered clinical entity, identified in 2-6% of the population by palpation, and 20-35% by ultrasound. DTC is the solid organ cancer with the most rapidly increasing incidence (>50,000 new cases in the U.S. annually). Despite extensive research and multiple published comprehensive practice guidelines, numerous controversies remain within this field covering a wide range of issues, including incidence and epidemiology, radiographic evaluation, criteria for needle biopsy, cytopathologic and molecular diagnostics, active surveillance vs. operation for low-risk tumors, extent of surgery, indications for radioactive iodine treatment and external beam radiation, and optimal protocols for follow-up. The book takes a case-based approach: each chapter will begin with a patient presentation highlighting a particular controversial subject in thyroid nodules and DTC. The remainder of the chapter discusses the controversy within the context of current scientific understanding and clinical practice, using the latest evidence-based practice guidelines. Chapters conclude with a final review and discussion of the opening case, with options and recommendations for next steps provided. The recommendations are evidence-based and practical, intended to help guide practitioners in their ongoing care of patients with thyroid nodules and DTC. Each chapter was written by a recognized expert in the area of controversy, including endocrine surgeons, endocrinologists, radiologists, medical oncologists, and nuclear medicine specialists. Controversies in Thyroid Nodules and Differentiated Thyroid Cancer: A Case-Based Approach is an excellent guide for oncologists, endocrinologists, otorhinolaryngologists, surgeons, and practitioners of all types that care for patients with thyroid nodules and DTC.Table of ContentsChapter 01: Incidence and Epidemiology of Differentiated Thyroid Cancer: Is thyroid cancer incidence truly increasing, or is it simply a finder effect?Chapter 02: Criteria for Fine-Needle Aspiration Biopsy in Thyroid NodulesChapter 03: Preoperative Molecular Testing for Indeterminate Thyroid NodulesChapter 04: Active Surveillance of Low-Risk Differentiated Thyroid CancerChapter 05: Preoperative Laryngoscopy in Thyroid Surgery PatientsChapter 06: Radiofrequency Ablation for Thyroid NodulesChapter 07: Management of low-risk papillary thyroid cancer in a patient with familial non-medullary thyroid cancer Chapter 08: Intraoperative Nerve Monitoring in Thyroid OperationsChapter 09: Extent of Surgery for Low-Risk Papillary Thyroid CancerChapter 10: Surgical Management of Locally Advanced Thyroid Cancer with Tracheal InvasionChapter 11: Management of Central Neck Nodes in Papillary Thyroid CancerChapter 12: Impact of Surgeon Volume in Thyroid OperationsChapter 13: Intraoperative/Postoperative Calcium Management in ThyroidectomyChapter 14: Indications for Radioactive Iodine Therapy in Thyroid Cancer PatientsChapter 15: Recurrent Nodal Metastases of Papillary Thyroid CancerChapter 16: Management of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Features (NIFT-P)Chapter 17: Timing of long-term post-operative surveillance for low-risk differentiated thyroid cancerChapter 18: External-Beam Radiation for Patients with Differentiated Thyroid Cancer – Is There a Role?
£98.99
Springer International Publishing AG Pancreatic Cancer: Current Therapeutics and
Book Synopsis Pancreatic cancer is a challenging and complex disease characterized by a dense fibrotic stroma and an immunosuppressive tumor microenvironment. Until recently, there were no predictive biomarkers to personalize selection of targeted or biologic therapies as a part of standard of care treatment. Moreover, the regulatory immune population of cells creates a “cold”, non-immunogenic tumor that is resistant to immunotherapies including checkpoint inhibitors. However, in the last few years, there has been substantial progress in our understanding of the role mutations in the pathogenesis of disease leading to increased adoption of germline and next generation sequencing to identify mutations and fusions to optimize selection of therapies and select patients for clinical trials of targeted agents.This book provides a comprehensive, global overview on therapy for pancreatic cancer, exploring approved therapies and focusing on the “Next” in drug development including molecularly targeted therapy and efforts at “Drugging the Undruggable”: the KRAS mutation. It also addresses efforts at targeting the inhospitable stroma to improve drug delivery to the tumor cells, incorporating ct DNA (liquid biopsies) in the care of patients and recent advances in immunotherapy. Pancreatic Cancer: Current Therapeutics and Future Directions will illuminate these challenges, review existing therapeutics, and highlight current and future efforts to improve outcomes in this devastating disease. Useful to physicians, fellows, medical students, residents, physician assistants, nurse practitioners, pharmaceutical companies and researchers interested in pancreatic cancer, it will first explain management of localized disease including resectability and adjuvant and neoadjuvant therapies. Targeted therapies including molecular, immunotherapy, stroma and role of ctDNA or “liquid biopsies” will be addressed. Finally, the book will explore the important role of pain management, diet and exercise in improving outcomes in pancreatic cancer.Table of ContentsResectable Pancreatic Cancer: Neoadjuvant and Adjuvant Therapy.- Borderline Resectable and Locally Advanced Pancreatic Cancer.- Radiation Therapy for Pancreatic Cancer: Current and Evolving Paradigms.- Therapies for Metastatic Pancreatic Cancer.- Targeted Therapies for Pancreatic Cancer.- Immunotherapy for Pancreatic Cancer.- Liquid Biopsies for pancreatic cancer: Is it ready for prime time?.- Supportive Care challenges and management in Pancreatic Cancer.- Physical activity and nutrition optimization in pancreatic cancer.
£98.99
Springer International Publishing AG Cancer Care in Pandemic Times: Building Inclusive
Book SynopsisThis open access edited volume focuses on the scope and benefits of strengthening local industrial-health linkages. The Covid-19 pandemic collapsed international supply chains for health. That experience brought home to African policy makers the critical nature of local manufacturing capabilities for sustaining and strengthening health care, and highlighted the pandemic benefits of India’s much stronger industrial base. At that time, a network of researchers in East Africa, India and the UK were investigating how to address the crisis of cancer care in low-resource health systems. Their project, uniquely, focused on the scope and benefits of strengthening local industrial-health linkages. The project researchers were also drawn into the pressing demands of Covid19 response. The result is this very timely book. The authors link their research on cancer to pandemic experience, and they draw sharp lessons for how countries can enhance their populations’ health security. The authors argue that improving cancer care is crucial for human wellbeing and more inclusive health care. They challenge policy makers to bring together health needs, health innovations and improved industrial capabilities to embed better cancer care and broader health system improvement in local industrial innovation and development.Table of ContentsPART 1 CANCER IN PANDEMIC TIMES CHAPTER 1 - THE CANCER CARE CHALLENGE IN THE LIGHT OF PANDEMIC EXPERIENCE CHAPTER 2 - BROKEN SUPPLY CHAINS AND LOCAL MANUFACTURING INNOVATION: RESPONSES TO COVID-19 AND THEIR IMPLICATIONS FOR POLICYPART 2 THE CANCER CARE EXPERIENCE IN EAST AFRICA CHAPTER 3 - THE SOCIAL PAIN OF CANCER IN EAST AFRICA: UNDERSTANDING NEEDCHAPTER 4: ACCESS TO CANCER CARE: NAVIGATING THE MAZECHAPTER 5 - BEYOND ‘LATE PRESENTATION’: EXPLAINING DELAYED CANCER DIAGNOSIS IN EAST AFRICA PART 3 LOCAL INDUSTRY AND CANCER CARE IN INDIA AND EAST AFRICA CHAPTER 6 - CUPBOARD FULL, CUPBOARD EMPTY: THE INDUSTRIAL BUILDING BLOCKS OF COVID-19 AND CANCER SYSTEMS CHAPTER 7- MANUFACTURING FOR CANCER CARE IN EAST AFRICA: RAISING THE AMBITION CHAPTER 8 - ONCOLOGY DRUG PRODUCTION IN SUB-SAHARAN AFRICA: THE CHALLENGE AND OPPORTUNITY, WITH EVIDENCE FROM INDIAPART 4 - INDUSTRIAL INNOVATION AND INDUSTRIAL POLICY CHAPTER 9 - EMERGING BUSINESS MODELS IN CANCER DIAGNOSTIC STARTUPS IN INDIA AND LESSONS FOR AFRICAN COUNTRIES CHAPTER 10 - REALISTIC AMBITIONS: TECHNOLOGY TRANSFER FOR BIOLOGICS PLATFORM TECHNOLOGIESCHAPTER 11 - PALLIATION ECONOMICS: THE INDUSTRIAL ORGANIZATION OF MORPHINE IN INDIAPART 5 - TACKLING INSTITUTIONAL GAPS: USING SCENARIOSCHAPTER 12 INNOVATION AND POLICY IN CANCER PAIN MANAGEMENT: SYSTEMIC INTERACTIONS IN TANZANIA CHAPTER 13 - USING SCENARIOS TO SUPPORT INNOVATION AND MUTUAL LINKAGES CHAPTER 14- CONCLUSION: BETTER CANCER CARE AND GREATER LOCAL HEALTH SECURITY: LESSONS, OPPORTUNITIES AND WAYS FORWARD
£33.24
Springer Neuroblastoma
Book SynopsisEpidemiology, Presentation, and Evaluation.- Pathology of Neuroblastoma.- Genetic Predisposition.- Part I: Evolving Concepts in Neuroblastoma Pathogenesis (Seed):Tumor Genomics: Copy Number Alterations.- Tumor Genomics: Epigenetics.- Tumor Genomics: Genomic Regulation .- Tumor Metabolism.- Part II: Evolving Concepts in Neuroblastoma Immunology and Tumor Microenvironment (Soil): Neuroblastoma Tumor Microenvironment - Adaptive and Innate Immunity.- Neuroblastoma Tumor Microenvironment Non-Immune Cells and Exosomes.- Part III: Evolving Concepts in Neuroblastoma Precision Medicine: Targeting the Seed and the Soil: Advances in evaluating tumor burden.- Therapeutically Actionable Genetic Aberrations.- Re-engaging the Immune System: Future of Immunotherapy.- Future of Clinical Trials and Application of Precision Medicine.- Summary and the Next 10 Years. <
£125.99
Springer Pathogens Associated with the Development of
Book Synopsis
£179.99
Thieme Publishing Group Head and Neck Cancer Recurrence: Evidence-based,
Book SynopsisDespite significant progress in the treatment of head and neck cancer using new techniques, including organ preservation strategies, recurrence still occurs in up to 50% of patients with locally advanced disease. Head and Neck Cancer Recurrence is the first comprehensive, evidence-based reference on this complex condition, providing state-of-the-art strategies for treating and managing recurrence at each site within the head and neck. With this book at hand, specialists will have guidelines for detecting the presence of a tumor, evaluating the extent and likelihood of successful salvage, determining the most effective treatment modalities, and assessing the potential impact on outcome and function. Special features: Brings together all the current evidence and expertise on the epidemiology, risk factors, clinical and imaging evaluation, and management of recurrent head and neck cancer tumors Includes both curative and palliative approaches, and discusses surgical, radiotherapeutic, and chemotherapeutic strategic options Contains substantial contributions by specialists in speech and language therapy, palliative care, psychology, epidemiology, and clinical cancer nursing to provide a holistic, multidisciplinary approach to the management of recurrence of head and neck cancers Brings the decision-making process to life with illustrative case studies that contain patient histories, clinical findings, treatment planning, and documented results The combination of the most recent clinical advances with the latest thinking in the field makes this book an essential resource for all head and neck surgeons, clinical oncologists, radiation oncologists, nurse practitioners, allied health professionals and senior trainees working to improve patient management and outcomes in this challenging arena.
£999.99
Kohlhammer Sinnzentrierte Psychotherapie Fur Patienten Mit
Book Synopsis
£47.20
Kohlhammer Psychoonkologie: Resilienz Innovativ Starken -
Book Synopsis
£999.99
S Karger AG Fast Facts Follicular Lymphoma
Book Synopsis
£18.75
Springer International Publishing AG Molecular Pathology in Clinical Practice
Book SynopsisThis authoritative textbook offers in-depth coverage of all aspects of molecular pathology practice and embodies the current standard in molecular testing. Since the successful first edition, new sections have been added on pharmacogenetics and genomics, while other sections have been revised and updated to reflect the rapid advances in the field. The result is a superb reference that encompasses molecular biology basics, genetics, inherited cancers, solid tumors, neoplastic hematopathology, infectious diseases, identity testing, HLA typing, laboratory management, genomics and proteomics. Throughout the text, emphasis is placed on the molecular variations being detected, the clinical usefulness of the tests and important clinical and laboratory issues.The second edition of Molecular Pathology in Clinical Practice will be an invaluable source of information for all practicing molecular pathologists and will also be of utility for other pathologists, clinical colleagues and trainees.Trade Review“This is an invaluable source of information for all practicing molecular pathologists, medical geneticists, pathology and genetics residents, and molecular pathology fellows. It also will be useful to surgical and clinical pathologists, hematologists, oncologists, internists, scientists who undertake disease-related basic science and translational research, and medical laboratory technologists. … All chapters are written by pathologists and scientists experienced in the practical applications of clinical molecular pathology tests. … I highly recommend this as one of the must-have and must-read books.” (Michel Nasr, Doody's Book Reviews, June, 2016)Table of ContentsChapter 1 Basics of Molecular Biology Deborah Ann PayneChapter 2 Molecular Pathology Methods D. Hunter Best, Shale A. Dames, Whitney Wooderchak-Donahue, Tracey Lewis, Kelli L. Sumner, Cecily P. Vaughn, Rong Mao and Daniel H. Farkas Part One Section I GeneticsElaine Lyon, Section EditorChapter 3 Genetic CounselingChristine E. MillerChapter 4 Pedigree Analysis and Risk AssessmentPatti Krautscheid and Danielle LaGraveChapter 5 Bayesian AnalysisRobert B. Wilson and Shuji OginoChapter 6 Intellectual Disability and Developmental Delay: Cytogenetic TestingGuangyu Gu, Reha Toydemir, Sarah T. SouthChapter 7 Developmental Delay: Gene TestingChristin D. Collins, Monica J. Basehore, Kristen J. Champion, Michael J. FriezChapter 8 Congenital Disorders of GlycosylationMelanie A. Jones and Madhuri R. HegdeChapter 9 Neuromuscular DiseasesThomas W. PriorChapter 10 Mitochondrial DisordersRenkui Bai and Jaime D. HiggsChapter 11 Metabolic DisordersLisa Edelmann, Yaping Yang, Amy C. Yang, Ruth KornreichChapter 12 Fibroblast Growth Factor Receptor and Related Skeletal DisordersSteven Sperber and Elaine SpectorChapter 13 Cystic FibrosisLora J.H. Bean and V. M. PrattChapter 14 DeafnessA. Eliot Shearer, Robert W. Eppsteiner, Richard J.H. SmithChapter 15 Coagulation DisordersRajiv K. Pruthi, Michelle L. Kluge, Aneel A. AshraniChapter 16 Hematologic Disorders: Hemochromatosis, Hemoglobinopathies, and Rh IncompatibilityDaniel B. Bellissimo and Archana Agarwal Chapter 17 Cardiovascular DiseaseSamantha M. Baxter and Birgit H. FunkeChapter 18 Neurodegenerative DisordersMaria Martinez-LageChapter 19 Polycystic Kidney DiseaseAdrian Y. Tan, Jon D. Blumenfeld and Hanna RennertChapter 20 Host Factor Pharmacogenetics for Treatment of Infectious DiseasesPatricia R. Slev and David R. HillyardChapter 21 PharmacogeneticsStuart A. Scott and Elaine LyonPart Two Inherited CancersHanna Rennert, Section EditorChapter 22 Inherited Breast CancerRachel Michaelson-Cohen, Rachel Beeri, Eliahu Golomb, Ephrat Levy-LahadChapter 23 Familial Adenomatous Polyposis and Turcot and Peutz-Jeghers SyndromesKandelaria M. RumillaChapter 24 Hereditary Nonpolyposis Colorectal Cancer and Lynch SyndromeJames P. GrenertChapter 25 Multiple Endocrine Neoplasia SyndromesBarbara A. ZehnbauerChapter 26 von Hippel-Lindau DiseaseCatherine A. StolleChapter 27 Hereditary Skin Cancer Dani Bercovich and Inbal KedarChapter 28 Li-Fraumeni Syndrome Arupa Ganguly and Zhao ChenChapter 29 Retinoblastoma Arupa Ganguly and Zhao ChenChapter 30 Hereditary Paraganglioma and PheochromocytomaFang-Yuan Li and Lee-Jun C. Wong Part Three Solid TumorsAntonia R. Sepulveda, Section EditorChapter 31 Colorectal CancerAntonia R. Sepulveda, Deqin Ma, Kathryn C. Behling, Helen FernandesChapter 32 Lung CancerDara L. Aisner, Robert C. Doebele, Marileila Varella-Garcia, Wilbur A. FranklinChapter 33 Breast Cancer Carolyn MiesChapter 34 Urothelial CarcinomaKevin C. HallingChapter 35 Prostate CancerPriti LalChapter 36 Thyroid CancerMarina N. Nikiforova and Yuri E. NikiforovChapter 37 Sarcomas and Related Mesenchymal TumorsGiovanni Tallini, Dario de Biase and Pei HuiChapter 38 GliomasEhud LaviChapter 39 Molecular Detection of Circulating Tumor Cells and Cell-Free Nucleic AcidsNirali M. Patel and Karen Kaul Part Four Neoplastic HematopathologyIris Schrijver, Section EditorChapter 40 Acute Myeloid LeukemiaDavid Grimwade, Steven Knapper, and Krzysztof MrózekChapter 41 Acute Lymphoblastic LeukemiaCarlos Alberto Scrideli, Giovanni Cazzaniga, and Andrea BiondiChapter 42 B-Cell MalignanciesJennifer B. Dunlap, Guang Fan, Nicky Leeborg, Rita M. BrazielChapter 43 T-Cell LymphomasJason D. Merker and Daniel A. ArberChapter 44 Myeloproliferative Neoplasms and Myelodysplastic SyndromesAlbert K. Ho and Daniel M. Jones Part Five Infectious DiseasesAngela M. Caliendo, Section EditorChapter 45 Human Immunodeficiency Virus Type 1Angela M. Caliendo and Colleen S. KraftChapter 46 Hepatitis B and C VirusesFrederick S. NolteChapter 47 Viral Infections in Transplant RecipientsRaymund R. Razonable and Randall T. HaydenChapter 48 Viral Infections of the Central Nervous SystemDuane W. Newton and Christine C. GinocchioChapter 49 Bacterial InfectionsKevin Alby and Melissa B. MillerChapter 50 Gastrointestinal InfectionsEileen M. Burd and Benjamin H. HinrichsChapter 51 Sexually Transmitted DiseasesJeanne A. JordanChapter 52 Respiratory InfectionsChristine C. GinocchioChapter 53 Mycobacterial InfectionsBetty A. Forbes Part Six Identity TestingVivianna M. Van Deerlin, Section EditorChapter 54 Forensic DNA TypingVictor W. Weedn and David R. ForanChapter 55 Parentage and Relationship TestingRobert W. Allen and Herbert F. Polesky†Chapter 56 Chimerism Testing in Allogeneic Hematopoietic Stem Cell TransplantationVivianna M. Van Deerlin and Ran ReshefChapter 57 Specimen Identification through DNA AnalysisGregary Bocsi, Andrew Ricci Jr., Gregory J. Tsongalis, Vivianna M. Van Deerlin Part Seven HLA TypingDebra G. B. Leonard, Section EditorChapter 58 Molecular HLA TypingMalek Kamoun, Jill A. Hollenbach, Steven J. Mack, Thomas M. Williams† Part Eight Evolving Clinical Molecular TechnologiesDebra G. B. Leonard, Section EditorChapter 59 Next Generation Sequencing: Principles for Clinical ApplicationKarl V. Voelkerding, Emily M. Coonrod, Jacob D. Durtschi, Rebecca L. MargrafChapter 60 Next Generation Sequencing for the Analysis of Cancer SpecimensJohn D. PfeiferChapter 61 Clinical Applications of ProteomicsDelphine Rolland and Kojo S.J. Elenitoba-Johnson Part Nine Laboratory Management Debra G. B. Leonard, Section EditorChapter 62 Molecular Pathology Laboratory ManagementHanna Rennert and Debra G.B. Leonard
£113.99
Springer International Publishing AG Difficult Decisions in Vascular Surgery: An
Book SynopsisThis book looks at specific vascular surgery questions that have arisen and where careful analysis is given according to the level of supporting evidence available. As new technology is introduced to treat the cardiovascular system, alternative therapies begin to challenge and also complement traditional vascular surgery. All chapters contain the PICO table to summarise specific characteristics relative to the questions posed in each chapter.Difficult Decisions in Vascular Surgery- An Evidence-Based Approach is a current and timely reference source for practicing surgeons, surgeons in training, and educators, that describes the recommended ideal approach, rather than customary care, in selected clinical situations.Trade Review“This is a useful resource for vascular trainees or vascular attendings throughout their careers as they face difficult situations that they do not encounter on a routine basis. … This is an accessible and well‐organized resource for dissecting the components of decision-making for clinical scenarios in vascular surgery. It provides a useful overview of the literature for each scenario and management recommendations graded by level of evidence. I found it to be a good resource.” (Katherine Hekman, Doody's Book Reviews, April, 2017)Table of ContentsSection 1: Aortic Disease Ch. 1: In patients with Acute Type B Aortic dissection, do current operative therapies reduce complications compared to medical management? Ch. 2: In patients with a Chronic Type B dissection, does Endovascular treatment reduce long term complications? Ch.3: In patients with a retrograde Type A Aortic dissection, does treatment like a type B Aortic dissection improve outcomes? Ch.4: In patients with small AAA, does medical therapy prevent growth? Ch.5: Challenging AAA Neck Anatomy: Does the Fenestrated or Snorkel/Chimney Technique Improve Mortality and Freedom from Reintervention Relative to Open Repair? Ch.6: In patients who require Hypogastric artery coverage to treat an AAA with EVAR, does preservation improve outcomes when compared to exclusion of the vessel? Ch.7: In patients with aortic graft infections, does EVAR improve long term survival compared to open graft resection? Ch.8: Does EVAR improve outcomes or quality of life in patients unfit for open surgery? Ch.9: In patients with type 2 endoleaks does intervention reduce aneurysm related morbidity and mortality compared to observation? Ch.10: Ruptured Abdominal Aortic Aneurysm Treated with Endovascular Repair; Does Decompressive Laparotomy Result in Improved Clinical Outcomes? Ch.11: In a Patient with Blunt Traumatic Aortic Injury, Does TEVAR Improve Survival Compared to Open Repair or Expectant Management? Section 2: Lower Extremity Arterial Disease Ch.12: In patients with Aortoiliac occlusive disease, does Endovascular repair improve outcomes when compared to open repair? Ch.13: In Patients with Aortoiliac Occlusive Disease, Does Extra-anatomic Bypass Improve Quality of Life and Limb Salvage? Ch.14: In Patients with Critical Limb Ischemia Does Bypass Improve Limb Salvage and Quality of Life When Compared to Endovascular Revascularization? Ch.16: In the patient with Profunda artery disease, is open revascularization superior to endovascular repair for improving rest pain? Ch.17: In patients with limb-threatening vascular injuries, is there a role of prophylactic fasciotomy to reduce ischemic injury? Ch.18: In patients with Popliteal Entrapment Syndrome, does surgery improve quality of life? Section 3: Mesenteric Disease Ch.19: In patients with Acute Mesenteric Ischemia does an endovascular or hybrid approach improve morbidity and mortality compared to open revascularization? Ch.20: Chronic Mesenteric Arterial Disease Does an endovascular/hybrid approach improve morbidity and mortality as compared to open revascularization? Ch.21: In patients with mesenteric ischemia is single vessel reconstruction equivalent to multiple vessel revascularization? Ch.22: In patients with celiac artery compression syndrome, does surgery improve quality of life? Ch.23: In patients with the Superior Mesenteric Artery syndrome is Enteric Bypass superior to Duodenal Mobilization Ch.24: In patients with Renovascular hypertension is there a role for open or endovascular revascularization compared to medical management? Ch.25: Does endovascular repair reduce the risk of rupture compared to open repair in splanchnic artery aneurysms? Section 4: Cerebrovascular Disease Ch.26: In patients with asymptomatic carotid artery stenosis does current best medical management reduce the risk of stroke compared to intervention (endarterectomy or stent)? Ch.27: In patients with symptomatic carotid artery stenosis is endarterectomy safer than carotid stenting? Ch.28: In Patients Undergoing Carotid Endarterectomy, is the Eversion Technique Superior to a Patch Technique to Reduce Restenosis? Ch.29: In patients with a stroke attributable to a carotid artery stenosis, does waiting to operate reduce the risk of complications? Ch.30: In patients with a peri-procedural cerebral thromboembolism, Does Neurovascular rescue improve Clinical Outcome? Ch.31: In patients with extra-cranial carotid artery aneurysms, does an endovascular approach improve clinical outcomes compared to open repair? Ch.32: In Patients with Carotid Artery Dissection, is Stenting Superior to Open Repair to Improve Clinical Outcomes? Ch.33: In patients with cervico-thoracic vascular injuries is endovascular repair superior in long-term durability when compared to open repair? Section 5: Venous and Arteriovenous Disease Ch.34: In Patients with Iliofemoral Deep Vein Thrombosis Does Clot Removal Improve Functional Outcome when Compared to Traditional Anticoagulation? Ch.35: In morbidly obese patients undergoing major abdominal operative procedures, does inferior vena cava filter placement prevent massive PE? Ch.36: In patients with chronic venous stenosis, does placement of a stent improve patency compared to recurrent angioplasty? Ch.37: In Patients with Chronic Venous Ulcer is the Unna Boot Still the Best Approach to Wound Care Ch.38: In Patients with Threatened or Occluded Access Grafts, Is it Better to Salvage the Graft, or Create a New Site? Ch.39: In patients with new arteriovenous fistulas, are there effective strategies to enhance AVF maturation and durability beyond waiting? Section 6: Perio-operative Management Ch.40: In patients with cardiovascular disease, do statins alone, or in combination with other medications improve mortality?Ch.41: In patients who have undergone a lower extremity bypass for PAD, does dual anti-platelet therapy improve outcomes?Ch.42: In patients undergoing vascular surgery, does preoperative coronary revascularization reduce the risk of myocardial infarction and death?
£999.99
Springer International Publishing AG Breast Oncology: Techniques, Indications, and
Book SynopsisThis book presents up to date debates and issues in the world of breast MRI with a very practical focus on how to incorporate current understanding of breast MRI into clinical practice. The book is divided into three key sections, all of which have critical impact for the breast imager: Techniques introduces the reader to the parameters of breast MRI from standard sequences to up-to-date cutting edge techniques. Indications provides a careful review of the accepted indications for breast MRI from High Risk Screening to use of breast MRI, in the context of neoadjuvant chemotherapy with a detailed analysis of the evidence-based support for these indications and a careful look at controversies and debates within the field. MRI Findings, Interpretation, and Management takes on the topics of how to interpret and manage specific MRI findings from benign to malignant disease with a focus on radiologic-pathologic correlation. The section also incorporates a focus on key management dilemmas, including appropriate follow-up intervals for benign findings on MRI and management of probably benign lesions assessed as a Breast Imaging Reporting and Dictating System (BI-RADS)-3 category on MRI.Trade Review“This book is a comprehensive overview of the now well-established technique of breast MRI in the assessment of breast disease. … This book is most likely to be of interest to radiologists in sub-specialty training in breast imaging, but would also be of interest as a reference text to consultant radiologists established in reporting breast MRI with a moderate level of experience. … The book is compact and well laid out.” (Mamatha Reddy, RAD Magazine, June, 2018)Table of ContentsSection 1. Techniques.- 1. Breast MRI Technique.- 2. Breast MRI: Standing Terminologies and Reporting.- Section 2. Indications.- 3. MRI and Screening.- 4. MRI and Preoperative Staging in Women Newly Diagnosed with Breast Cancer.- 5. Magnetic Resonance Imaging and Noeadjuvent Chemotherapy.- 6. Breast MRI and Implants.- 7. Problem Solving Breast MRI for Mammographic, Sonographic, or Clinical Findings.- 8. Post-Operative findings/recurrent disease.- Section 3. MRI Findings, Interpretation and Management.- 9. In Situ Disease on Breast MRI.- 10. MRI appearance of Invasive Breast Cancer.- 11. Targeted Ultrasound after MRI.- 12. Breast Biopsy and Breast MRI Wire Localization.- 13. Breast MRI and the Benign Breast Biopsy.- 14. BI-RADS 3 Lesions on MRI.- 15. Multiparametric Imaging: Cutting-Edge Sequences and Techniques including Diffusion-Weighted Imaging, Magnetic Resonance Spectroscopy, and PET/CT or PET/MRI.- 16. Abbreviated Breast MRI.- 17. Personalized Medicine, Biomarkers of Risk and Breast MRI.
£125.99
Springer International Publishing AG Pediatric Radiation Oncology
Book SynopsisThis book presents the most up-to-date and innovative information on the targeting and treatment of a wide range of childhood cancers by means of radiation therapy. Written by global experts in pediatric radiation oncology, it documents in detail the treatment regimens appropriate to each disease, highlighting the recent advances that promise to improve rates of survival and cure. The use of image-guided and intensity-modulated radiation therapy is clearly described, and careful attention is also devoted to the roles of proton therapy, stereotactic radiosurgery, stereotactic fractionated radiosurgery, and modulated arc radiotherapy. Separate chapters address localization and verification procedures and anesthesia; pediatric radiation oncology in the palliative care setting; and aspects that are especially relevant in low- and medium-income countries. Beyond clinical radiation oncology, relevant information is provided on radiation physics. The book concludes by examining future directions in the field.Trade Review“This is an excellent complement and fortifies the libraries of both radiation and pediatric oncologists. … its updates in the rapidly changing molecular landscape of pediatric tumors, and its clear descriptions of the inexorable evolution of radiation technology, make it important reading for students, trainees, and practitioners from all disciplines who treat children with cancer.” (Bernadine Rose Donahue, Doody's Book Reviews, June, 2018)“This book provides an excellent summary of common intracranial and extracranial pediatric malignancies treated with radiation therapy, with a focus on radiation specific treatment guidelines and clinical outcome data. The book is best suited for radiation oncologists or anyone looking for a comprehensive overview of the diagnosis and management strategies for the diseases included.” (Bree R. Eaton, Neurosurgery, Vol. 84 (3), March, 2019)Table of ContentsEwing Sarcoma and DSRCT.- Rhabdomyosarcoma.- Soft-tissue Sarcoma and Osteosarcoma.- Neuroblastoma.- Wilms Tumor.- Retinoblastoma and Rare Solid Tumors.- Glioma.- Medulloblastoma and SPNET.- ATRT.- CNS Germ Cell Tumors.- Ependymoma.- Craniopharyngioma.- Stem Cell Transplantation.- Leukemia/ Lymphoma.- Hodgkin Lymphoma.- Radiation Physics. Proton Therapy.- Localization, Verification, and Anesthesia.- Palliative Care.- Low and Medium Income Countries.- Future Directions.
£119.99
Springer International Publishing AG Atlas of Mohs and Frozen Section Cutaneous
Book SynopsisOf all the techniques used to treat non melanoma skin cancer, the highest cure rates belong to the Mohs surgical procedure. Critical to this technique is optimal preparation and interpretation of frozen sections. The second edition of this highly successful atlas details both common and uncommon cutaneous neoplasms that can serve as a source of reference for established practitioners and a review for those in training. It includes new frozen section specimens, the most current diagnostic guidelines, and discussion of the advancements in tissue staining. There is also an additional chapter with self-study tools, where readers can test their knowledge using various images with a multiple choice answer format, followed by a discussion of the correct answer. With high resolution figures, the Atlas of Mohs and Frozen Section Cutaneous Pathology, Second Edition is the premier text on the topic, serving as a highly practical guide to microscopic analysis, diagnosis, and discrimination of common and problematic cutaneous neoplasms. Highlights of the Atlas include diagnosis of basic and routine dermatologic entities, diagnosis and distinction of rare and/or deadly neoplasms such as dermatofibrosarcoma protuberans and merkel cell carcinoma, a troubleshooting guide dealing with quality control of the frozen section technique, and discussion of techniques including immunohistochemistry. Comprehensive and presented in full color, the Atlas of Mohs and Frozen Section Cutaneous Pathology, Second Edition is an indispensable reference for anyone involved with the Mohs procedure, including dermatologic surgeons, Mohs cutaneous surgeons, as well as pathologists and dermatopathologists who perform frozen section analysis of cutaneous specimens.Table of ContentsContentsSection I: Introduction1 Mohs and Frozen Section OverviewMichael B. Morgan, Terri Bowland2 Quality Assurance Dennis H. Nguyen, Daniel M. Siegel, Deborah Zell, Richard Spallone, Michael B. MorganSection II: Tumors of the Epidermis/Adnexae3 Histology with Regional and Ethnic Variation Michael B. Morgan, John R. Hamill, Jr.4 Benign Epidermal Tumors Michael B. Morgan5 Pseudotumors Martin Dunn, Michael B. Morgan6 Squamous Cell Carcinoma: Variants and Challenges Michael B. Morgan7 Basal Cell Carcinoma: Variants and Challenges Michael B. Morgan8 Adnexal Neoplasms Michael B. Morgan9 Malignant Adnexal Neoplasms Ryan S. Jawitz, Jack C. Jawitz, Michael B. Morgan10 Merkel Cell Carcinoma Michael B. Morgan11 Sebaceous Tumors Michael B. Morgan12 Paget’s Disease Michael B. Morgan13 Melanocyte Pathology Michael B. MorganSection III: Tumors of the Dermis14 Benign Mesenchymal Tumors Michael B. Morgan15 The Sarcomas Aaron M. Bruce, James M. Spencer16 Lymphoid Pathology John R. Hamill Jr., Michael B. MorganSection IV: Special Topics17 Perineural Pathology Martin Dunn, Michael B. Morgan18 Cytopathology of Cutaneous Tumors Kenneth B. Calder, Rahel Mathew, Michael B. Morgan19 Immunohistochemistry Applications Basil S. Cherpelis, L. Frank Glass, John R. Hamill Jr., Neil Alan Fenske20 Histotechnique and Staining Troubleshooting John R. Hamill Jr., Stephen SpencerSection V: Mohs Clinicopathologic Self-Test Series 21 A Painful Perineural Infiltrate Rebecca S. Thornhill, Tyler Scott22 A Painful Subcutaneous Nodule Rebecca S. Thornhill, Nicole Asher23 Basaloid LesionTyler Scott, Nicole Asher 24 Rapidly Growing Hemorrhagic PapuleRebecca S. Thornhill, Nicole Asher 25 Aggressive Spindle Cell NeoplasmRebecca S. Thornhill, Tyler Scott 26 Eyelid Tumor Nicole Asher, Tyler Scott27 Non-melanoma Skin Cancer with Anemia Rebecca S. Thornhill, Tyler Scott28 Follicular Neoplasm Tyler Scott, Nicole Asher29 Hemorrhagic Papule in a Patient with Lip Carcinoma Rebecca S. Thornhill, Tyler Scott30 Blue Ball in the DermisRebecca S. Thornhill, Nicole Asher
£142.49
Springer International Publishing AG Comprehensive Atlas of Dermatoscopy Cases
Book SynopsisThis practical atlas describes the use of dermoscopy in the clinic, a technique that is increasingly used by the clinical dermatologist. It revolves around the use of clinical cases, simulating what happens in the clinic when the dermatologist is presented with a patient who has pigmented lesions. Dermatologists perform diagnoses based on what they see on the skin and with these images recognize different diseases. This whole spectrum of forms and shapes is reflected in colour. Dermoscopy opens a new and very wide field of structures and colors that can not be seen with the naked eye and, with appropriate training and the use of this book, improves our clinical diagnosis. Comprehensive Atlas of Dermatoscopy Cases teaches the technique through specially selected clinical cases that cover the entire field of dermoscopy, providing the reader a thorough understanding of the techniques and methodologies associated with diagnosis using dermatoscopy. It is of great use to the trainee dermatologist and any practicing dermatologist seeking to expand their skills with this important diagnostic tool. Table of ContentsStructures, patterns, criteria, colours and two-step procedure.- Non melanocytic lesions: Seborrheic keratosis.- Non melanocytic lesions: Lentigo solar.- Non melanocytic lesions: Basal cell carcinoma.- Non melanocytic lesions: Angiomas & angiokeratomas.- Non melanocytic lesions: Dermatofibroma.- Non melanocytic lesions: Actinic keratoses.- Non melanocytic lesions: Squamous cell carcinoma.- Melanocytic lesions: Criteria of melanocytic lesions.- Melanocytic lesions: Melanocytc nevus.- Melanocytic lesions: Spitz nevus.- Melanocytic lesions: Blue nevus & combined nevus.- Melanocytic lesions: Recurrent nevus.- Melanocytic lesions: Melanoma.- Melanocytic lesions: Melanoma simulators.- Melanocytic lesions: Combined lesions.- Melanocytic lesions: Other less frequent lesions.- Clinical cases (from 1 to 100).
£149.99
Springer International Publishing AG The Papanicolaou Society of Cytopathology System
Book SynopsisThis text presents comprehensive review of the recommendations of the Papanicolaou Society of Cytopathology for reporting results of respiratory cytology specimens along with advances in diagnostic, prognostic, and predictive immunohistochemical and molecular techniques which can be performed on cytology specimens.The majority of the text focuses on the standardized terminology and nomenclature for respiratory cytology as recommended by the Papanicolaou Society of Cytopathology. Each of the diagnostic categories are described in depth and formal definitions for each category are given along with cytologic criteria. Explanatory notes are given discussing limitations of the category as well as its malignancy risk and reproducibility. Management recommendations are supplied for each category. Sample reports documenting the preferred reporting format are also given. Each category is associated with a reference list establishing the evidence based nature of the categories.An in depth discussion of ancillary testing is provided, including the utilization of microbiologic culture, immunohistochemistry, and molecular techniques. Substantial emphasis is placed on molecular diagnostics necessary for optimization of personalized testing and the appropriate use of targeted therapies. The text represents a comprehensive resource for the state of the science of the cytologic diagnosis of respiratory lesions.Trade Review“All figures and tables are accompanied by useful legends. A very useful feature is the group of appendixes, which serves as a condensed version of the book and can be used for a quick lookup of criteria. As a book that aims to standardize respiratory cytology reporting, its ultimate success lies in the acceptance by practicing cytopathologists. … this book is a well‐written and much‐needed guideline from the Papanicolaou Society to further push for standardization of cytopathology reporting.” (Keluo Yao, Doody's Book Reviews, May 10, 2019)Table of ContentsOverview of Diagnostic Terminology and Reporting.- Category I: Non-Diagnostic.- Category II: Negative (for Malignancy).- Category III: Atypical.- Category IV: Neoplastic: Benign.- Category IV: Neoplasm-Undetermined Malignant Potential.- Category V: Suspicious for Malignancy.- Category VI: Malignant.- Recommendations for Ancillary Testing.
£47.49
Springer International Publishing AG Cancer and AIDS: Part IV: Future Perspectives
Book SynopsisThe lifestyles and socio-economic status that are prevalent in regions of the world with limited resources form the background for the unique features of neoplastic diseases in these areas, where the majority of the world population lives. The predominance of the world’s retroviral burden of in these areas further compounds the nature and challenges of the cancer there. Much of the international cancer literature covers the nature and challenges of the disease as seen in high-income regions of the world, thereby giving a skewed view of the global cancer challenges. As the low- and middle-income regions of the world transition from communicable to non communicable disease patterns, there is a need for a corresponding paradigm shift, with increased emphasis on what the world needs to know about non communicable diseases, including cancer, where the disease is hitherto poorly documented. The main goal of the proposed book is to contribute to this outcomes.Table of ContentsPart IV: Future Perspectives Chapter 10 – Strategies for progress Abstract Section 10.1.0: The role of international partnership in the development of global health systems Section 10.1.1: Models of humanitarian global outreach in health care Section 10.1.2: The concept of “convergence” and the future of health care research Section 10.1.3.0: The concept of global health Section 10.1.3.1: Models of global health partnership in cancer control Section 10.1.3.2: The tiered resource stratification framework of the Breast Health Global Initiative (BHGI) Network Section 10.1.3.3: ASCO’s resource-stratified guidelines for the management of invasive cervical cancer Section 10.1.3.4: NCCN framework for resource stratification for invasive cervical cancer Section 10.1.3.5: Resource-stratified approaches in the primary prevention of cervical cancer Section 10.1.3.5.1 ASCO resource-stratified guideline for the primary prevention of cervical cancer Section 10.1.3.6: Resource-stratified approaches in the secondary prevention of cervical cancer Section 10.1.3.4.1: Selected Global Health Activities for promoting cancer control/Health Volunteers Overseas (HVO) Section 10.1.3.4.2 Global Curriculum and Mentoring Program Section 10.1.3.4.3: Global Curriculum and Mentoring Program/International Development and Education Award Section 10.1.3.4.4: Proposal for recognizing global oncology as an academic field Section 10.2: Overcoming barriers to progress in the control of cancer and retroviral diseases, including HIV/AIDS Section 10.2.1: Prioritizing strategies for universal health coverage Section 10.2.1.1: mHealth Strategies for Universal Health Coverage Section 10.2.1.2: Community Health Insurance Coverage as a strategy for Universal Health Care Section 10.2.1.3: Innovation in provider training as a strategy in UHC Section 10.2.2: The role of politics in attainment of Universal Health Coverage Section 10.2.3: The role of science and engineering in human welfare Section 10.2.3.1: The role of science Section 10.2.3.1.1: Science advocacy Section 10.2.3.1.2: Science education in low- and middle-income countries Section 10.2.3.1.3 Examples of the transforming effect of science in LMICs Section 10.2.3.1.3.1 Impact of science on the emergence of South Korea Section 10.2.3.1.3.2: Impact of science on Middle-Eastern cooperation Section 10.2.3.1.3.3: Impact of the US-Cuba scientific diplomacy Section 10.2.3.1.3.4: Boosting science in Singapore Section 10.2.3.1.3.5: India boosts its ambitious space program Section 10.2.3.2: Transforming the practice of engineering to meet global health needs Section 10.2.3.3 Models in innovation with potentials for cancer and HIV/AIDS control in LMICs Section 10.2.3.3.1: Affordable, weather durable x-ray machine Section 10.2.3.3.2: Affordable cancer immunotherapy in Cuba Section 10.2.3.3.3: The smart village for rural electrification Section 10.2.3.3.4: HIV/AIDS control in China Section 10.3: The future of control of cancer and retroviral diseases Page 1055: Section 10.3.1: From the National Cancer Act to the 21st Century Cures Act Page 1059: Section 10.3.2: Advances in lung cancer prevention Page 1062: Section 10.3.3: Ending the HIV/AIDS pandemic Page 1063: Section 10.3.4: Finding a cure for AIDS – a possible convergence of cancer and HIV/AIDS researchIndex
£80.99
Springer International Publishing AG Essentials of Interventional Cancer Pain
Book SynopsisThis text provides a comprehensive review and expertise on various interventional cancer pain procedures. The first part of the text addresses the lack of consistency seen in the literature regarding interventional treatment options for specific cancer pain syndromes. Initially, it discusses primary cancer and treatment-related cancer pain syndromes that physicians may encounter when managing cancer patients. The implementation of paradigms that can be used in treating specific groups of cancer such as breast cancer, follows. The remainder of the text delves into a more common approach to addressing interventional cancer pain medicine. After discussing interventional options that are commonly employed by physicians, the text investigates how surgeons may address some of the more severe pain syndromes, and covers the most important interventional available for our patients, intrathecal drug delivery. Chapters also cover radiologic options in targeted neurolysis and ablative techniques, specifically for bone metastasis, rehabilitation to address patients’ quality of life and function, and integrative and psychological therapies. Essentials of Interventional Cancer Pain Management globally assesses and addresses patients’ needs throughout the cancer journey. Written by experts in the field, and packed with copious tables, figures, and flow charts, this book is a must-have for pain physicians, residents, and fellows.Table of ContentsPart I: Perspectives on Cancer Pain Medicine.- Perspectives on Interventional Cancer Pain Management.- The Practice of Cancer Pain: A Case Series.- Part II: Cancer Pain Syndromes.- Pathophysiology of Cancer Cancer Pain.- Chemotherapy.- Post-Surgical Pain Syndromes.- Radiation-Induced Pain Syndromes.- Part III: Paradigms in Cancer Pain Syndromes.- General Pain Management Concepts.- Head and Neck.- Breast Cancer Pain: A Review of Pathology and Interventional Techniques.- Thoracic Cancer Pain.- Gastrointestinal Cancer Pain.- Genitourinary Cancer Pain Syndromes.- Pediatrics.- Pain in Hematologic Malignancies.- Dermatologic Cancer Pain Syndromes.- Part IV: Percutaneous Pain Techniques and Anatomy.- Ablative Techniques.- Sympathetic Nervous System Blocks for the Treatment of Cancer Pain.- Peripheral Nerve Blocks. Cranial Nerve Targets.- Vertebroplasty, Kyphoplastly, and Sacroplasty.- Treatment Considerations for Cancer Pain Syndromes.- Part V: Surgical Techniques Electrical Modulation.- Intracranial Neuroablation.- Spinal Neuroablation for Cancer Pain.- Radiosurgery.- Deep Brain Stimulation and Motor Cortical Stimulation for Malignant Pain.- Spinal Cord Stimulation and Oncologic Pain Management.- Peripheral Nerve Stimulation for the Treatment of Cancer Pain.- Transcutaneous Electrical Nerve Stimulation for Cancer Pain.- Part VI: Intrathecal Drug Delivery.- Indications for Intrathecal Pump Therapy.- Intrathecal Drug Delivery System Trialing for Cancer Pain Management.- Pump Implantation Technique.- Medications in Intrathecal Pumps.- Compounding Drugs for Intrathecal Use.-Part VII: Interventional Oncology.- Image Guidance and Planning.- Ablative Techniques for Painful Metastasis (PFA, Cryo, Chemical, HIFU).- Introduction to Radiation Therapy.- Palliative Radiation Therapy.- External Beam Radiotherapy in the Treatment of Painful Bone Mestastases.- Non-Opioid Intravenous Infusions for Management of Cancer Associated Pain.- Part VIII: Interventional Physiatry.- Cancer Rehabilitation.- Neuromuscular Medicine-Cancer Pain.- Cancer-Related Pelvic Pain.- Exercise Therapy and Fatigue Management.- Physical Therapy.- Occupational Therapy.- Cancer Pain and Physical Modalities.- Osteopathic Treatment for Cancer-Related Pain.- Rehabilitation Bracing as a Conservative Treatment Option.- Part IX: Complementary and Psycho-Behavioral Therapies.- Psycho-social Assessment and Treatment for Patients with Cancer Pain.- Relaxation Techniques and Biofeedback for Cancer Pain Management.- Mood and Anxiety in Cancer Pain.- Acupuncture and Cancer Pain.- Creative Therapies and Mind-Body Health Systems.- Botanical Treatments in Cancer Pain Management.- Integrative Therapies for Pain Modulation.
£999.99
Urban & Fischer/Elsevier Komplementäre Onkologie
Book Synopsis
£35.10
Urban & Fischer/Elsevier TherapieHandbuch Neurologie
Book Synopsis
£35.10
Urban & Fischer/Elsevier TherapieHandbuch Gastroenterologie und
Book Synopsis
£53.10
Urban & Fischer/Elsevier TherapieHandbuch Onkologie und Hämatologie
Book Synopsis
£48.60
Urban & Fischer/Elsevier Facharztwissen Hämatologie Onkologie
Book Synopsis
£99.20
Urban & Fischer/Elsevier Schlaffibel für Kinder und Jugendliche
Book Synopsis
£999.99
Urban & Fischer/Elsevier TherapieHandbuch Infektionskrankheiten und
Book Synopsis
£999.99
Urban & Fischer/Elsevier TherapieHandbuch Nephrologie
Book Synopsis
£26.10
Urban & Fischer/Elsevier TherapieHandbuch Pneumologie
Book Synopsis
£35.10
Urban & Fischer/Elsevier BASICS Onkologie
Book Synopsis
£24.30
Wiley-VCH Verlag GmbH TNM Klassifikation maligner Tumoren: Korrigierter
Book SynopsisDie TNM-Klassifikation ist das weltweit am häufigsten verwendete System für die Beschreibung der anatomischen Ausbreitung maligner Tumoren, gegliedert in einen klinischen und einen pathologischen Teil. Sie wird in Zusammenarbeit mit der Union for International Cancer Control (UICC) herausgegeben und umfasst im Wesentlichen alle anatomischen Regionen gemäß den WHO-Richtlinien zur Klassifikation der Krankheiten in der Onkologie. Dieser korrigierte Nachdruck der 8. Auflage berücksichtigt rund 150 Änderungen und Korrekturen aus den Jahren 2017 bis 2019, die nach Erscheinen der 8. Auflage von der UICC bekannt gegeben wurden.Table of ContentsVorwort xi Danksagungen xv Nationale Komitees und internationale Organisationen xvii Mitglieder der TNM-Komitees der UICC xix Herausgeber der einzelnen Abschnitte xxi Einleitung 1 Kopf- und Halstumoren 25 Mundhöhle 27 Pharynx 32 Larynx 44 Nasenhöhle und Nasennebenhöhlen 50 Unbekannter Primӓrtumor mit Metastasen der Halslymphknoten 55 Malignes Melanom des oberen Aerodigestivtraktes 62 Große Speicheldrüsen 64 Schilddrüse 69 Tumoren des Verdauungstraktes 75 Ösophagus einschließlich ösophagogastraler Übergang 77 Magen 85 Dünndarm 90 Appendix 93 Kolon und Rektum 97 Analkanal und perianale Haut 103 Leber 107 Intrahepatische Gallengӓnge 111 Gallenblase und Ductus cysticus 114 Perihilӓre Gallengӓnge 117 Distale extrahepatische Gallengӓnge 120 Ampulla Vateri 123 Pankreas 126 Gut differenzierte neuroendokrine Tumoren des Gastrointestinaltraktes 130 Lungen-, Pleura- und Thymustumoren 141 Lunge 142 Pleuramesotheliom 151 Thymustumoren 154 Knochen- und Weichteiltumoren 157 Knochen 158 Weichteile 163 Gastrointestinaler Stroma Tumor (GIST) 167 Hauttumoren 173 Karzinom der Haut 175 Hautkarzinom des Kopf-Hals-Bereiches 179 Karzinom der Haut des Augenlids 183 Malignes Melanom der Haut 186 Merkelzellkarzinomder Haut 191 Mammatumoren 195 Gynäkologische Tumoren 207 Vulva 209 Vagina 213 Cervix uteri 216 Uterus – Endometrium 222 Uterussarkome (Leiomyosarkom, Endometriales Stromasarkom, Adenosarkom) 227 Ovar, Tube und primӓres Peritonealkarzinom 231 Trophoblastӓre Schwangerschaftstumoren 237 Urologische Tumoren 241 Penis 242 Prostata 245 Hoden 249 Niere 254 Nierenbecken und Harnleiter 257 Harnblase 259 Harnröhre 264 Nebennierenrindentumoren 267 Augentumoren 271 Karzinom der Konjunktiva 272 Malignes Melanom der Konjunktiva 274 Malignes Melanom der Uvea 278 Retinoblastom 284 Orbitasarkom 289 Karzinom der Trӓnendrüsen 291 Hodgkin-Lymphom 293 Non-Hodgkin-Lymphome 297 Essentielles TNM 299 Kindertumoren 305
£999.99
Wiley-VCH Verlag GmbH TNM Atlas
Book SynopsisTNM Atlas Der maßgebende Atlas zur aktuellen TNM Klassifikation — jetzt mit noch mehr Illustrationen Das TNM System ist das weltweit am häufigsten verwendete Werkzeug, die Ausbreitung einer Krebserkrankung zu klassifizieren und in Stadien einzuteilen. Herausgegeben in Zusammenarbeit mit der UICC (Union for International Cancer Control) stellt der TNM Atlas, Siebte Auflage, die illustrierte Version der TNM Klassifikation, Achte Auflage, dar. Dieses Werk unterstützt mit erstklassigen anatomischen Darstellungen bei der praktischen Anwendung des TNM Klassifikationssystems. T- und N-Kategorien werden mit klaren und einfach zu verstehenden Abbildungen illustriert, ergänzt durch ausgewählte tomographische Aufnahmen aus der klinischen Praxis. Inhaltlich vollkommen überarbeitet, basierend auf der aktuellen TMN Klassifikation Mit mehr als 300 farbigen Abbildungen, die die anatomischen Besonderheiten jeder Tumorerkrankung akkurat und detailgetreu darstellen Unverzichtbares Werk nicht nur für die Diagnose, sondern auch für Ausbildung und für Aufklärungsgespräche mit Patient⋆innen Die in Genf ansässige UICC ist eine weltweit anerkannte Organisation, deren zentrale Aufgabe die Tumorklassifikation und Krebsbekämpfung ist. Ihr TNM Atlas ist ein wertvolles Nachschlagewerk für Onkolog⋆innen, Chirurg⋆innen, Patholog⋆innen, Mitarbeitende in Krebsregistern und onkologisches Pflegepersonal, sowie für Krebsforschungsinstitute und entsprechende staatliche Einrichtungen und nichtstaatliche Organisationen.Table of ContentsVorwort Zur Siebten Auflage vii Danksagung viii Mitwirkende Der Siebten Auflage ix Erläuternde Vorbemerkungen x Kopf- Und Halstumoren 1 Lippen Und Mundhöhle 17 Pharynx 28 Larynx 50 Nasenhöhle Und Nasennebenhöhlen 60 Unbekannter Primärtumor Mit Metastasen Der Halslymphknoten 70 Malignes Melanom Des Oberen Aerodigestivtrakts 74 Grosse Speicheldrüsen 77 Schilddrüse 82 Tumoren Des Verdauungstrakts 89 Ösophagus Einschliesslich Ösophagogastraler Übergang 90 Magen 98 Dünndarm 105 Appendix 110 Kolon Und Rektum 116 Analkanal 126 Leber – Hepatozelluläres Karzinom 132 Leber – Intrahepatische Gallengänge 137 Gallenblase 141 Perihiläre Extrahepatische Gallengänge 147 Distale Extrahepatische Gallengänge 151 Ampulla Vateri 154 Pankreas 161 Gut Differenzierte Neuroendokrine Tumoren Des Gastrointestinaltrakts 167 Gut Differenzierte Neuroendokrine Tumoren Des Pankreas 179 Lungen- Pleura- Und Thymustumoren 183 Lunge 184 Pleuramesotheliom 196 Thymustumoren 203 Knochen- Und Weichteiltumoren 213 Knochen 214 Weichteile 221 Gastrointestinaler Stromatumor 228 Hauttumoren 231 Karzinom Der Haut 236 Hautkarzinome Des Kopf-hals-bereichs 240 Karzinom Der Haut Des Augenlids 249 Malignes Melanom Der Haut 256 Merkelzellkarzinom Der Haut 267 Mammatumoren 271 Gynäkologische Tumoren 291 Vulva 292 Vagina 298 Cervix Uteri 305 Uterus Endometrium 315 Uterus – Uterussarkome 321 Ovar Tuba Uterina Und Primäres Peritonealkarzinom 329 Trophoblastäre Schwangerschaftstumoren 337 Urologische Tumoren 341 Penis 342 Prostata 350 Hoden 358 Niere 375 Nierenbecken Und Harnleiter 384 Harnblase 390 Urethra 396 Nebennierenrindentumoren 406 Hodgkin-lymphome 410 Non-hodgkin-lymphome 425
£999.99
Wiley-VCH Verlag GmbH Fundamentals of Cancer Detection, Treatment, and
Book SynopsisFundamentals of Cancer Detection, Treatment, and Prevention The professional guide to cancer diagnosis and therapy for researchers and clinicians In Fundamentals of Cancer Detection, Treatment, and Prevention, distinguished researcher Surya K. De delivers a concise and authoritative guide to cancer treatment, diagnosis, and prevention. The book offers a comprehensive overview of cancer in humans, from its causes, symptoms, and diagnosis to the variety of treatment options available today. Intuitively organized by cancer type, this guide provides concise information on risk factors, diagnosis, and treatment options for all commonly encountered tumors, including surgery, radiation therapy, chemotherapy, and immunotherapy. All US FDA-approved drugs—like small molecules, peptides, monoclonal antibodies, whole antibodies, gene therapy, antibody-drug conjugates, and cell therapies—are considered, and information about their generic and brand names, clinical uses, and mechanisms of action is presented. Readers will also find: A thorough overview of human cancers, including cancer risk factors and possible preventions Comprehensive explorations of bladder, blood, brain, and spinal cord cancers Practical discussions of breast, colorectal, cervical, kidney, and liver cancer In-depth examinations of lung, skin, ovarian, vaginal, vulvar, pancreatic, and prostate cancers, as well as mesothelioma Perfect for pharmaceutical chemists, oncologists, pharmacologists, and medicinal chemists, Fundamentals of Cancer Detection, Treatment, and Prevention is an indispensable guide for professional researchers, whether they are working in the clinic or the pharmaceutical industry.Table of ContentsPreface xxiii About the Book xxv About the Author xxvii Common Abbreviations and Acronyms xxix 1 An Overview of Cancer 1 1.1 Introduction 1 1.2 Cancer Statistics 1 1.3 Differences Between Normal Cells and Cancer Cells 2 1.4 Types of Cancer 4 1.4.1 Carcinomas 4 1.4.2 Sarcomas 4 1.4.3 Leukemias 4 1.4.4 Lymphomas 4 1.5 The Role of Genes and Chromosomes 5 1.6 Genetic Mutations 7 1.6.1 Acquired Mutations 7 1.6.2 Germline Mutations 7 1.7 Genes Connected to Cancer 7 1.7.1 Tumor Suppressor Genes 7 1.7.2 Oncogenes 8 1.7.3 DNA Repair Genes 8 1.8 Tumors and Metastasis 9 1.9 Hereditary Cancer Risk 10 1.10 Cancer Screening and Diagnosis 10 1.10.1 Colon Cancer 11 1.10.2 Lung Cancer 11 1.10.3 Breast/Cervical/Ovarian/Endometrial Cancers 11 1.10.4 Prostate Cancer 12 1.10.5 Liver Cancer 12 1.10.6 Skin Cancer 12 1.11 Cancer Treatment Options 13 1.11.1 Surgery 13 1.11.2 Radiation Therapy 13 1.11.3 Chemotherapy 14 1.11.4 Targeted Therapy 14 1.11.5 Immunotherapy 14 1.11.6 Hormone Therapy 14 1.11.7 Stem Cell Transplant 15 1.11.8 Precision Medicine 15 References 15 2 Cancer Risk Factors and Prevention 21 2.1 Introduction 21 2.2 Hormones 21 2.3 Immunosuppression and Infectious Agents 22 2.4 Chronic, Long-term, DNA-damaging Inflammation 23 2.5 Being Overweight/Obese 23 2.6 Eating to Win 24 2.6.1 Vegetables 26 2.6.2 Fruits 26 2.6.3 Grains 26 2.6.4 Proteins 26 2.6.5 Bread 26 2.6.6 Cereal 26 2.6.7 Dairy 26 2.6.8 Snacks 26 2.6.9 Beverages 26 2.6.10 Spices 27 2.7 Role of Sugar and Artificial Sweeteners on Cancer 27 2.8 Role of Certain Foods and Drinks on Cancer 27 2.8.1 Processed Meat and Fish 27 2.8.2 Alcohol 28 2.9 Role of Smoking or Tobacco Use on Cancer 29 2.10 Role of Radiation on Cancer 30 2.11 Role of Sunlight and UV Radiation on Cancer 31 2.12 Role of Radon on Cancer 33 2.13 Known Human Carcinogens 33 2.13.1 Arsenic, Coal Tar, Coal-tar Pitch, Diesel, Asbestos, Formaldehyde, and Air Pollutants 33 2.13.2 Certain Types of Plastic 37 2.13.3 Acrylamide 37 2.14 Possible Human Carcinogens 39 2.15 Guidelines for Early Detection of Cancer 39 References 40 Further Reading 50 3 Bladder Cancer 51 3.1 Introduction 51 3.2 Genes Associated with Bladder Cancer 51 3.3 Types of Bladder Cancer 51 3.4 Symptoms of Bladder Cancer 52 3.5 Diagnosis 52 3.6 Methods of Treatment 53 3.6.1 Surgical Transurethral Resection of Bladder Tumor (TURBT) 53 3.6.2 Radiation Therapy 53 3.6.3 Photodynamic Therapy 53 3.6.4 Chemotherapy 53 3.6.5 Targeted Therapy 53 3.6.6 Immunotherapy 53 3.7 Treatment Regimens 54 3.8 Risk Factors/Possible Prevention 57 References 57 4 Cancers of the Blood 67 4.1 Introduction 67 4.2 Genes Associated with Blood Cancer 67 4.3 Types of Blood Cancers 68 4.4 Blood Cancer Symptoms 70 4.5 Diagnosis 70 4.6 Methods of Treatment 70 4.6.1 Stem Cell Transplantation 71 4.6.2 Targeted Radiation Therapy 71 4.6.3 Chemotherapy 71 4.6.4 Targeted Drug Therapy 71 4.7 List of Drugs for Different Types of Blood Cancers 71 4.7.1 Drugs for Acute Lymphoblastic Leukemia 71 4.7.2 Drugs for Acute Myeloid Leukemia (AML) 71 4.7.3 Drugs for Chronic Lymphocytic Leukemia 72 4.7.4 Drugs for Chronic Myelogenous Leukemia (CML) 72 4.7.5 Drugs for Hairy Cell Leukemia 72 4.7.6 Drug(s) for Mast Cell Leukemia 72 4.7.7 Drug(s) for Meningeal Leukemia 72 4.7.8 Drugs for Hodgkin Lymphoma 72 4.7.9 Drugs for Non-Hodgkin Lymphoma 72 4.7.10 Drugs for Multiple Myeloma and Other Plasma Cell Neoplasms 73 4.8 Leukemia Treatment regimens 73 4.8.1 Treatment Regimens for Acute Lymphocytic (Lymphoblastic) Leukemia (ALL) 73 4.8.2 Acute Myeloid (or Myelogenous) Leukemia (AML) Treatment Regimens 76 4.8.3 Chronic Lymphocytic Leukemia Treatment Regimens 80 4.8.4 Chronic Myeloid Leukemia (CML) Treatment Regimens 83 4.8.5 Hairy Cell Leukemia Treatment Regimens 85 4.9 Hodgkin’s Lymphoma Treatment Regimens 85 4.10 Non-Hodgkin’s Lymphoma Treatment Regimens 89 4.11 Cutaneous T-Cell Lymphoma Treatment Regimens 96 4.12 Primary CNS Lymphoma Treatment Regimens 97 4.13 Multiple Myeloma Treatment Regimen 98 4.14 Risk Factors and Possible Preventions 105 References 105 5 Brain and Spinal Cord Tumors 133 5.1 Introduction 133 5.2 Genes Associated with Brain Cancer 133 5.3 Types of Primary Brain Tumors for Adults 133 5.3.1 Astrocytoma 134 5.3.2 Oligodendroglioma 135 5.3.3 Meningioma 135 5.4 Types of Brain Cancer for Children 135 5.4.1 Medulloblastoma 135 5.4.2 Grade I or II Astrocytoma 135 5.4.3 Ependymoma 135 5.4.4 Brainstem Glioma 135 5.5 Brain Tumor Symptoms 136 5.6 Diagnosis 136 5.6.1 Neurological Exam 136 5.6.2 Imaging Tests 136 5.6.3 Biopsy 137 5.7 Methods of Treatment 137 5.7.1 Surgery 137 5.7.2 Radiation Therapy 137 5.7.3 Radiosurgery 137 5.7.4 Chemotherapy 137 5.7.5 Targeted Drug Therapy 138 5.8 Treatment Regimens 138 5.9 Post-Treatment Rehabilitation 141 5.10 Risk Factors/Possible Preventions 141 References 142 6 Breast Cancer 151 6.1 Introduction 151 6.2 Genes Associated with Breast Cancer (Pathophysiology) 151 6.3 Describing Breast Cancer 151 6.4 Breast Cancer Symptoms 153 6.5 Diagnosis 153 6.5.1 Breast Examination 153 6.5.2 Imaging Tests 153 6.5.3 Biopsy 153 6.6 Methods of Treatment 154 6.6.1 Surgery 154 6.6.1.1 Lumpectomy 154 6.6.1.2 Mastectomy 154 6.6.1.3 Sentinel Node Biopsy 154 6.6.1.4 Axillary Lymph Node Dissection 154 6.6.1.5 Reconstruction 154 6.6.2 Radiation Therapy 154 6.6.3 Chemotherapy 155 6.6.4 Hormone-Blocking Therapy 155 6.6.5 Targeted Therapy 155 6.6.6 Immunotherapy 155 6.6.7 Abbreviations for a Chemotherapy Combination Used to Treat Breast Cancer 156 6.6.8 Drugs to Prevent Breast Cancer 156 6.7 Drugs for Breast Cancer in Men 156 6.8 Treatment Regimens 157 6.8.1 Preoperative/Adjuvant Therapy Regimens for HER2-Negative Breast Cancer 157 6.8.2 Preoperative/Adjuvant Therapy Regimens for HER2-Positive Breast Cancer 160 6.8.3 Systemic Therapy for ER- and/or PR-Positive Recurrent or Stage IV (M1) Disease: HER2-Negative and Postmenopausal or Premenopausal Receiving Ovarian Ablation or Suppression 162 6.8.4 Systemic Therapy Regimens for Recurrent/Unresectable/Advanced/ Metastatic Stage IV Breast Cancer: Regimens for HER2-Negative Disease 165 6.8.5 Systemic Therapy for ER- and/or PR-Positive Recurrent or Stage IV (M1) Disease: Regimens for HER2-Positive Postmenopausal or Premenopausal Receiving Ovarian Ablation or Suppression 169 6.8.6 Systemic Therapy Regimens for Recurrent/Unresectable/Advanced/ Metastatic Stage IV Breast Cancer: Regimens for HER2-Positive Disease 172 6.9 Risk Factors/Possible Preventions 176 References 177 7 Colorectal Cancer 193 7.1 Introduction 193 7.2 Genes Associated with Colorectal Cancer 193 7.3 Colorectal Cancer Symptoms 193 7.4 Stages 195 7.5 Diagnosis 195 7.6 Methods of Treatment 195 7.6.1 Surgery 196 7.6.2 Radiation Therapy 196 7.6.3 Chemotherapy 196 7.6.4 Targeted Therapy 196 7.6.5 Immunotherapy 196 7.7 Drugs to Anal Cancer 197 7.8 Drugs to Prevent Anal Cancer 197 7.8.1 Treatment Regimens for Colorectal Cancer: Adjuvant/Advanced/Metastatic Disease 197 7.8.2 Systemic Therapy for Advanced or Metastatic Disease 198 7.8.3 Treatment Regimens for Anal Cancer: Regimens for Localized Stage 205 7.8.4 Treatment Regimens for Anal Cancer: Metastatic Stage 205 7.9 Risk Factors/Possible Preventions 207 References 207 8 Cervical Cancer 219 8.1 Introduction 219 8.2 Causes of Cervical Cancer 219 8.3 Symptoms of Cervical Cancer 219 8.4 Diagnosis 220 8.5 Methods of Treatment 221 8.5.1 Surgery 221 8.5.2 Radiation Therapy 221 8.5.3 Chemotherapy 221 8.5.4 Targeted Therapy 221 8.5.5 Immunotherapy 221 8.6 Vaccines to Prevent Cervical Cancer 221 8.7 Treatment Regimens: Systemic Therapy for Recurrent or Metastatic Cervical Cancer 222 8.8 Risk Factors/Possible Preventions 225 References 225 9 Kidney Cancer 233 9.1 Introduction 233 9.2 Genes Associated with Kidney Cancer 233 9.3 Types of Kidney Cancer 234 9.4 Kidney Cancer Symptoms 234 9.5 Diagnosis 234 9.5.1 Urine Tests 235 9.5.2 Blood Tests 235 9.5.3 Biopsy 235 9.5.4 Intravenous Pyelogram 235 9.5.5 Ultrasound 235 9.5.6 Computed Tomography Scan 235 9.5.7 Magnetic Resonance Imaging 235 9.5.8 Renal Arteriogram 235 9.6 Kidney Cancer Stages 236 9.7 Methods of Treatment 236 9.7.1 Simple Nephrectomy 236 9.7.2 Partial Nephrectomy 236 9.7.3 Radical Nephrectomy 237 9.7.4 Radiofrequency Ablation 237 9.7.5 Arterial Embolization 237 9.7.6 Cryotherapy 237 9.7.7 Radiation Therapy 237 9.7.8 Chemotherapy 237 9.7.9 Targeted Drug Therapy 237 9.7.10 Immunotherapy 237 9.7.11 Complementary or Alternative Treatment 238 9.7.12 Drugs for Upper Tract Urothelial Cancer 238 9.7.13 Drugs for Wilms’ Tumor and Other Childhood Kidney Cancers 238 9.8 Treatment Regimens 238 9.9 Risk Factors/Possible Preventions 240 References 241 10 Liver (Hepatocellular) Cancer 247 10.1 Introduction 247 10.2 Gene Associated with Liver Cancer and Role of Hepatitis Infection 247 10.3 Liver Cancer Symptoms 247 10.4 Diagnosis 248 10.5 Methods of Treatment 249 10.5.1 Surgery 249 10.5.2 Liver Transplant 249 10.5.3 Ablation Therapies 249 10.5.4 Embolization 249 10.5.5 Radiation Therapy 249 10.5.6 Chemotherapy 249 10.5.7 Targeted Therapy 249 10.5.8 Immunotherapy 250 10.6 Treatment Regimens 250 10.7 Liver (Hepatocellular) Cancer Risk Factors/Possible Preventions 252 References 252 11 Lung Cancer 259 11.1 Introduction 259 11.2 Genes Associated with Lung Cancer 259 11.3 Types of Lung Cancer 260 11.4 Symptoms of Lung Cancer 260 11.5 Diagnosis 261 11.5.1 Imaging Tests 261 11.5.2 Sputum Cytology 262 11.5.3 Tissue Biopsy 262 11.6 Methods of Treatment 262 11.6.1 Surgery 262 11.6.2 Radiation Therapy 262 11.6.3 Chemotherapy 262 11.6.4 Targeted Drug Therapy 262 11.6.5 Immunotherapy 263 11.6.6 Drugs by Types of Lung Cancer 263 11.6.6.1 Drugs for Non-Small Cell Lung Cancer 263 11.6.6.2 Drugs for Small Cell Lung Cancer 263 11.7 Treatment Regimens 264 11.7.1 Treatment Regimens for Non-Small Cell Lung Cancer 264 11.7.2 Treatment Regimens for Small Cell Lung Cancer 270 11.8 Risk Factors and Possible Preventions 273 References 273 12 Melanoma (Skin Cancer) 285 12.1 Introduction 285 12.2 Genes Associated with Melanoma 285 12.3 Types of Melanoma 285 12.3.1 Superficial Spreading Melanoma 285 12.3.2 Nodular Melanoma 286 12.3.3 Lentigo Maligna Melanoma 286 12.3.4 Acral Lentiginous Melanoma 286 12.4 Stages of Malignant Melanoma 286 12.5 Symptoms of Melanoma Cancer 287 12.6 Diagnosis 287 12.6.1 Asymmetric 287 12.6.2 Border 287 12.6.3 Color 287 12.6.4 Diameter 288 12.6.5 Evolving 288 12.7 Methods of Treatment 288 12.7.1 Surgery 288 12.7.2 Radiation 288 12.7.3 Chemotherapy 288 12.7.4 Targeted Therapy 289 12.7.5 Immunotherapy 289 12.7.6 Photodynamic Therapy 289 12.8 Drugs for Other Types of Skin Cancer 289 12.8.1 Drugs for Basal Cell Carcinoma 289 12.8.2 Drugs for Cutaneous Squamous Cell Carcinoma 289 12.8.3 Drugs for Merkel Cell Carcinoma 289 12.8.4 Drugs for Kaposi Sarcoma 290 12.9 Treatment Regimens 290 12.10 Melanoma Risk Factors 293 12.11 Possible Prevention 294 12.11.1 Sun Protection Tips 294 12.11.2 What about Vitamin D? 295 References 295 13 Mesothelioma 305 13.1 Introduction 305 13.2 Genes Associated with Mesothelioma 305 13.3 Types of Mesothelioma Cancers 305 13.4 Mesothelioma Cancer Symptoms 305 13.4.1 Symptoms for Pleural Mesothelioma 305 13.4.2 Symptoms for Peritoneal Mesothelioma 307 13.4.3 Symptoms for Pericardial Mesothelioma 307 13.4.4 Symptoms for Testicular Mesothelioma 307 13.5 Diagnosis 307 13.6 Methods of Treatment 307 13.6.1 Surgery 307 13.6.2 Radiation Therapy 308 13.6.3 Chemotherapy 308 13.6.4 Targeted Therapy 308 13.6.5 Immunotherapy 308 13.7 Treatment Regimens 308 13.8 Possible Prevention 310 13.9 Occupational Exposure Prevention 310 13.9.1 Employer Responsibilities 310 13.9.2 Employee Responsibilities 311 13.10 Household Exposure Prevention 311 References 311 14 Ovarian, Vaginal, and Vulvar Cancer 317 14.1 Introduction 317 14.2 Genes Associated with Ovarian, Vaginal, and Vulvar Cancer 318 14.3 Symptoms of Ovarian, Vaginal, and Vulvar Cancer 318 14.4 Diagnosis 319 14.5 Methods of Treatment 320 14.5.1 Surgery 320 14.5.2 Radiation Therapy 320 14.5.3 Chemotherapy 320 14.5.4 Hormone Therapy 320 14.5.5 Targeted Therapy 320 14.6 Drugs for Vaginal Cancer 320 14.7 Drugs to Prevent Vaginal Cancer 321 14.8 Drugs to Treat Vulvar Cancer 321 14.9 Drugs to Prevent Vulvar Cancer 321 14.10 Treatment Regimens 321 14.10.1 Treatment Regimens for Germ Cell Ovarian Cancer 327 14.11 Risk Factors/Possible Preventions 328 References 328 15 Pancreatic Cancer 341 15.1 Introduction 341 15.2 Genes Associated with Pancreatic Cancer 341 15.3 Symptoms of Pancreatic Cancer 342 15.4 Diagnosis 342 15.5 Methods of Treatment 342 15.5.1 Surgery 343 15.5.2 Radiation Therapy 343 15.5.3 Chemotherapy 343 15.5.4 Targeted Therapy 343 15.5.5 Immunotherapy 343 15.5.6 Drugs for Gastroenteropancreatic Neuroendocrine Tumors 343 15.6 Treatment Regimens for Pancreatic Cancer 344 15.7 Risk Factors and Possible Preventions 346 References 347 16 Prostate Cancer 355 16.1 Introduction 355 16.2 Genes Associated with Prostate Cancer 355 16.3 Symptoms of Prostate Cancer 356 16.4 Diagnosis 356 16.5 Methods of Treatment 357 16.5.1 Surgery 357 16.5.2 Radiation Therapy 357 16.5.3 Cryotherapy 357 16.5.4 Chemotherapy 358 16.5.5 Targeted Therapy 358 16.5.6 Immunotherapy 358 16.5.7 Hormone Therapy 358 16.6 Treatment Regimens 358 16.7 Risk Factors/Possible Preventions 362 References 363 17 Stomach (Gastric) Cancer 371 17.1 Introduction 371 17.2 Genes Associated with Stomach Cancer 371 17.3 Symptoms of Stomach Cancer 372 17.4 Stages of Stomach Cancer 373 17.5 Diagnosis 374 17.6 Methods of Treatment 375 17.6.1 Surgery 375 17.6.2 Endoluminal Stent Placement 375 17.6.3 Endoluminal Laser Therapy 375 17.6.4 Gastrojejunostomy 375 17.7 Radiation Therapy 376 17.8 Chemotherapy 376 17.9 Targeted Medications 376 17.10 Immunotherapy 376 17.11 Treatment Regimens for Stomach Cancer 376 17.12 Risk Factors 383 17.12.1 Certain Medical Conditions 383 17.12.2 Smoking 383 17.12.3 Helicobacter Pylori Infection 383 17.12.4 Family History 384 17.12.5 Foods Containing Aflatoxins 384 17.12.6 Diet 384 17.12.7 Age 384 17.12.8 Gender 384 17.12.9 Previous or Existing Cancers 384 17.12.10 Some Surgical Procedures 384 17.13 Possible Preventions 384 References 385 18 Thyroid Cancer 395 18.1 Introduction 395 18.2 Genes Associated with Thyroid Cancer 395 18.3 Types of Thyroid Cancer 395 18.3.1 Papillary Thyroid Cancer 395 18.3.2 Follicular Thyroid Cancer 395 18.3.3 Medullary Cancer 396 18.3.4 Anaplastic Thyroid Cancer 396 18.4 Thyroid Cancer Symptoms 396 18.5 Diagnosis 397 18.6 Staging of Thyroid Cancer 397 18.6.1 Papillary or Follicular Thyroid Cancer Patients under the Age of 45 397 18.6.2 Papillary or Follicular Thyroid Cancer Patient Aged 45 Years and Older 397 18.6.3 Medullary Thyroid Cancer 398 18.6.4 Anaplastic Thyroid Cancer 398 18.7 Methods of Treatment 399 18.7.1 Surgery 399 18.7.2 Radioactive Iodine Ablation 399 18.7.3 External Beam Radiation 399 18.7.4 Thyroid Hormone Therapy 399 18.7.5 Chemotherapy 399 18.7.6 Targeted Therapy 399 18.8 Treatment Regimens 400 18.9 Possible Preventions 402 References 402 19 Endometrial Cancer 407 19.1 Introduction 407 19.2 Genes Associated with Endometrial Cancer 407 19.3 Symptoms 407 19.4 Endometrial Cancer Diagnosis 408 19.4.1 Internal Pelvic Exam 408 19.4.2 Pap Test (also called Pap Smear) 408 19.4.3 Endometrial Biopsy 408 19.4.4 Dilation and Curettage (Also Called D&C) 409 19.4.5 Transvaginal Ultrasound 409 19.5 Stages 409 19.6 Methods of Treatment 409 19.6.1 Surgery 409 19.6.1.1 Hysterectomy 410 19.6.1.2 Salpingo-oophorectomy 410 19.6.1.3 Pelvic Lymph Node Dissection 410 19.6.1.4 Para-aortic Lymphadenectomy 410 19.6.1.5 Laparoscopic Lymph Node Sampling 410 19.6.1.6 Sentinel Lymph Node Mapping 410 19.6.2 Radiation Therapy 410 19.6.2.1 External Radiation Therapy 410 19.6.2.2 Internal Radiation Therapy 410 19.6.3 Chemotherapy 410 19.6.4 Targeted Therapy 411 19.6.5 Immunotherapy 411 19.6.6 Hormone Therapy 411 19.7 Treatment Regimens 411 19.8 Risk Factors of Endometrial Cancer 415 19.9 Prevention 415 References 416 20 Penile Cancer 423 20.1 Introduction 423 20.2 Symptoms of Penile Cancer 423 20.3 Penile Cancer Diagnosis 424 20.3.1 Biopsy 424 20.3.2 Imaging Tests 424 20.4 Methods of Penile Cancer Treatment 424 20.4.1 Surgery 424 20.4.1.1 Circumcision 424 20.4.1.2 Other Surgical Procedures 425 20.4.2 Local Treatments (Other than Surgery) for Penile Cancer 425 20.4.2.1 Laser Ablation 425 20.4.2.2 Cryosurgery/Cryotherapy 425 20.4.2.3 Photodynamic Therapy (PDT) 425 20.4.3 Radiation Therapy 425 20.4.4 Chemotherapy 425 20.4.4.1 Topical Chemotherapy 425 20.4.4.2 Systemic Chemotherapy 425 20.5 Treatment Regimens for Penile Cancer 425 20.6 Risk Factors of Penile Cancer 427 20.7 Penile Cancer Prevention 427 References 428 21 Testicular Cancer 431 21.1 Introduction 431 21.2 Symptoms of Testicular Cancer 431 21.3 Diagnosis 432 21.3.1 Ultrasound 432 21.3.2 A Physical Exam and Medical History 432 21.3.3 Blood Tests for Tumor Markers 432 21.3.3.1 Biopsy 433 21.3.4 CT Scan and X-ray 433 21.4 Methods of Treatment 433 21.4.1 Surgical Treatment 433 21.4.2 Radiation Therapy 433 21.4.3 Chemotherapy 433 21.5 Treatment Regimens for Testicular Cancer 433 21.6 Risk Factors 435 21.6.1 An Undescended Testicle 435 21.6.2 Family History of Testicular Cancer 436 21.6.3 HIV Infection 436 21.6.4 Race 436 21.6.5 Infertility 436 21.6.6 Certain Activities 436 21.6.7 Reducing Exposure to Chemical Toxins 436 21.7 Prevention 436 21.8 Self-Exam of Testicular Cancer 437 References 437 Index 443
£71.25
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Das Maligne Melanom: Derzeitiger Stand in
Book SynopsisIn }bersichtlicher Weise werden der derzeitige Stand der Diagnostik, Differentialdiagnostik, histopathologischen Klassifikation, Prognose bzw. die verschiedensten Therapie- formen des malignen Melanoms aufgezeigt. Offenen Fragen hin- sichtlich der Weite der Tumorexzision und der prophylakti- schen, regionalen Lymphknotendissektion werden diskutiert. Die chirurgische Therapie steht im Mittelpunkt der Behand- lung, wobei jedoch immer eine interdisziplin{re Zusammen- arbeitzwischen Dermatologen, Chirurgen, Onkologen und Ra- diotherapeuten erforderlich ist.Table of ContentsEpidemiologie des malignen Melanoms.- „Sonne ohne Reue“ — Ergebnisse der Aufklärungskampagne „Malignes Melanom“.- Risikofaktoren beim malignen Melanom.- Malignes Melanom — Früherkennung.- Früherkennung des malignen Melanoms.- Malignes Melanom in Österreich. Retrospektive Analyse des Patientenkollektivs der I. Universitäts-Hautklink Wien (1963–1988).- Zur Epidemiologie des malignen Melanoms an der Grazer Hautklinik von 1970 bis 1988.- Auflichtmikroskopische Kriterien zur Differentialdiagnose von pigmentierten Hautveränderungen.- Die Bedeutung der Epilumineszenzmikroskopie für die präoperative Diagnostik pigmentierter Hautläsionen.- Differentialdiagnose des malignen Melanoms.- Prognose und Stadieneinteilung beim malignen Melanom.- Klinik und Histologie des malignen Melanoms.- Schnellschnittdiagnostik bei malignem Melanom.- Schnellschnitte — Pro oder Contra?.- Die Positronenemissionstomographie (PET): Eine neue Methode zur Funktionsdiagnostik und Therapieplanung bei Patienten mit malignem Melanom.- Chirurgisches Therapieschema des malignen Melanoms (ACO-Richtlinien).- Richtlinien der CAO zur Diagnostik und Behandlung des malignen Melanoms.- Die chirurgische Therapie des malignen Melanoms — Operationstechniken und Ergebnisse mit Hilfe der Fibrinklebung.- Die Notwendigkeit und Bedeutung des Sicherheitsabstandes bei der Therapie des Melanoms der Haut im Stadium I.- Die stadiengerechte Therapie der Körperstamm-Melanome unter Berücksichtigung der elektiven Lymphknotendissektion.- Elektive Lymphknotendissektion bei malignem Melanom.- Der enge Indikationsbereich der ELND — vorläufige Ergebnisse einer vergleichenden Studie.- Plastisch-chirurgische Rekonstruktionen nach Melanom-Resektion.- Chirurgische Probleme bei malignen Melanomen im Kopf- und Halsbereich.- Malignant melanoma of the nasal cavity and upper jaw.- Melanome der Vagina und der Vulva.- Das anorektale Melanom.- Palliative chirurgische Therapie beim malignen Melanom.- Die chirurgische Behandlung von Hirnmetastasen.- Operationsindikation beim solitären pulmonalen Rundherd des Melanompatienten.- Epidermotrope Melanommetastasen.- Operative Strategie bei Melanommetastasen.- Die isolierte hypertherme Extremitätenperfusion.- Langzeitergebnisse nach 538 isolierten hyperthermen Extremitätenperfusionen beim malignen Melanom.- Laktatanstieg nach hyperthermer Extremitätenperfusion — ein Maß für die intraoperative Muskelalteration.- Vermeidung systemischer Komplikationen der isolierten Cytostatikaperfusion der Extremitäten durch Leckkontrolle mittels 111-Indium markierter Erythrocyten.- Isolierte Mehrfachperfusion der Extremitäten am Hund — eine experimentelle Studie.- Immuntherapie beim malignen Melanom.- Aktive spezifische Immuntherapie (ASI) bei malignem Melanom — Stadium II und IV.- Neue Ansätze in der Immuntherapie mit Immunmodulatoren bei Patienten mit metastasierendem Melanom.- Interferonbehandlung des metastasierenden Melanoms.- Chemotherapie des malignen Melanoms.- Radiotherapie beim malignen Melanom.- Behandlung des metastasierenden malignen Melanoms mit einem Endotoxin enthaltenden Bakterienlysat. Ergebnisse einer Pilot-Studie.- Nachsorge bei malignem Melanom.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Praktische Schmerztherapie in der Onkologie
Book SynopsisDie Schmerztherapie für Tumorpatienten erfordert eine enge Zusammenarbeit der einzelnen medizinischen Fachdisziplinen. Das vorliegende Buch umfaßt Beiträge zur Schmerzentstehung, zu den diagnostischen Verfahren und zu den verschiedenen Methoden der Schmerzlinderung. Gesondert werden die Schmerztherapie bei Kindern sowie die psychosoziale Betreuung von Krebspatienten behandelt. Den Abschluß bildet ein Bericht über die Erfahrungen einer interdisziplinären onkologischen Schmerzambulanz.Table of ContentsDas nozizeptive System und seine Beeinflußbarkeit durch Pharmaka beim Karzinomschmerz.- Diagnostische Maßnahmen zur Erkennung der Schmerzursache.- Schmerztherapie bei Kindern.- Strahlentherapie schmerzhafter Knochenmetastasen.- Rückenmarksnahe Analgesie bei Tumorschmerz.- Neurochirurgische Verfahren der Schmerzausschaltung.- Patientenführung bei Krebsschmerz.- Administrative Aspekte der Opiatverschreibung.- Erfahrungsbericht einer interdisziplinär geführten Schmerzambulanz.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Weichgewebetumoren: Interdisziplinäres Management
Book SynopsisDie Herausgeber, anerkannte Spezialisten und aktiv in der Interdisziplinären Arbeitsgruppe Weichteilsarkome (IAWS) der Deutschen Krebsgesellschaft, stehen für fundiertes Fachwissen. Das Werk zeichnet sich durch eine praxisorientierte und übersichtliche Darstellung aller bei Weichteilsarkomen klinisch relevanten Themen aus. Ausführlich wird auf Diagnostik, Klassifikation, Stadieneinteilung wie auch molekulare und genetische Aspekte als Grundlage therapeutischer Entscheidungen eingegangen. Ein weiteres zentrales Thema ist die interdisziplinäre Behandlung (Chirurgie, Strahlentherapie, medikamentöse Therapie) und deren Sequenz für die zahlreichen, unterschiedlichen Entitäten von Weichteilsarkomen. Auch spezielle Therapieverfahren, wie Extremitätenperfusion und Hyperthermie werden besprochen. Ärzte in Klinik und Praxis erhalten mit diesem Buch kompetente Unterstützung für die optimale Betreuung von Patienten mit Weichteilsarkomen.Table of ContentsI. Epidemiologie II. Diagnostik III. Chirurgische Therapie IV. Strahlentherapie V. Medikamentöse Therapie VI. Spezifische Therapieverfahren VII. Nachsorge, Rehabilitation und PsychoonkologieAnhang
£26.59
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Hilfreiche Gespräche und heilsame Berührungen im
Book SynopsisProfessionelle Kommunikation ist in der Pflege ebenso wichtig wie Diagnose und Therapie. Dazu zählen Gespräche wie auch Berührungen, die heilsam sind. Die Autorinnen, beide mit langjähriger Erfahrung im Umgang mit Schwerkranken, beschreiben in verständlicher Sprache die Grundlagen der menschlichen Kommunikation. Anschaulich schildern viele Beispiele und Fotos den Verlauf hilfreicher Gespräche und Formen heilsamer Berührungen. Ein bewährter Ratgeber für eine einfühlsame Kommunikation mit kranken, alten und sterbenden Menschen.Trade ReviewAus den Rezensionen zur 4. Auflage: “... speziell für professionell Pflegende und engagierte Laien geschrieben ... Durch Praxisbeispiele, Erfahrungsberichte, Fotos und literarische Texte lernt der Leser einfühlsame Gespräche und wohltuende Berührungen umsetzen zu können ...“ (in: beatmet leben, 2013, Issue 2)Table of ContentsEinführende Gedanken: Kommunikation als Heilkraft.- Kommunikation: Entwicklungsgeschichte und Theorieansätze. Grundbegriffe der Kommunikation. Berührung - Beziehung - Mitteilung. Das Kommunikationsmodell von Schulz v. Thun. Nonverbale Kommunikation.- Angewandte Kommunikation: Persönliche Voraussetzungen. Hilfen für ein gutes Gespräch. "Berührende Gespräche". Das biographische Gespräch. Kommunikation mit alten, verwirrten Menschen. Kommunikation in der Sterbebegleitung. Literatur, Texte, Fallbeispiele. Sprache-Gespräch-Aussprache: Eine Form der Lebensbewältigung. Wenn es Zeit ist, zu gehen: Worte und Berührungen am Ende des Lebens.
£26.59
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Diagnose-Schock: Krebs: Hilfe für die Seele -
Book SynopsisDiagnose-Schock: KrebsDiagnose Krebs: Über 500.000 Menschen in Deutschland, Österreich und der Schweiz erhalten jährlich die Diagnose Krebs. Die medizinischen Fragestellungen haben dann Priorität, oft wird aber die psychologische Betreuung der Patienten auch im Verlauf der Behandlung zu wenig berücksichtigt. Studien zeigen zudem, dass die Partner Krebsbetroffener häufig noch stärker belastet sind als die Patienten. Hilfe für die Seele Dieses Buch bietet praktische Unterstützung für beide Seiten: Patienten und ihre Partner, Freunde, Begleiter. Ziele des Buches: - Sorgen und Hilflosigkeit vermindern- Ihre Lebensqualität verbessern - Selbsthilfe und Selbststeuerung anregen- Sie unterstützen, mit der Erkrankung umzugehen und für sich selbst zu sorgen- Sie unterstützen, Ihren eigenen Weg zu finden- Ihnen in schwierigen Situationen Möglichkeiten aufzeigen- Sie unterstützen, wichtige Dinge nicht zu verpassen.Als klinisch tätige Psychoonkologen zeigen die Autoren vielfach erprobte Hilfestellungen auf. Leserinnen und Leser erhalten kurze, gut lesbare Erklärungen und Anleitungen, die die Ressource Menschlichkeit nutzen. Geschrieben ist das Buch für Betroffene und Angehörige sowie für medizinische und psychosoziale Fachleute in Klinik, Praxis und Reha, die mit Krebsbetroffenen arbeiten. Der praktische Ratgeber für Betroffene und Angehörige: In der Krise lesbar und bezogen auf den ganzen MenschenTrade ReviewAus den Rezensionen: “Das handliche Buch bildet ein klar strukturiertes Kompendium psychologischer und psychoonkologischer (Er-)Kenntnisse ... Ein gut lesbarer Ratgeber für Betroffene und Angehörige. Für medizinisches und psychosoziales Fachpersonal eine hilfreiche Darstellung möglicher Auswirkungen der Diagnose Krebs.“ (Manfred Gaspar, in: Zeitschrift für Palliativmedizin, März 2014, Jg. 15, Heft 2)Table of Contents1. Klärungen als Hilfe.- 2. Hilfen zum Umgang mit schwierigen Situationen.- 3. Hilfen zum Umgang mit schwierigen Gefühlen.- 4. Praktische Hilfen zur Lebensgestaltung.- 5. Hilfen zum Umgang mit unheilbarer Krankheit.- 6. Erfahrungsberichte.- 7. Empfohlene Literatur und Internet-Links.- 8. Psychoonkologische Beratung und Therapie.
£16.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Histological Diagnosis of Nevi and Melanoma
Book SynopsisThe interpretation of melanocytic tumors represents probably the most difficult task in the field of dermatopathology. The second edition of this text and atlas depicts a broad range of the most important and most challenging melanocytic lesions. Each individual case is illustrated with at least three high-quality color photographs and is commented on at length, highlighting the diagnostic clues. The goal of the authors is to assist the ordinary pathologist in making a precise workable diagnosis in their daily practice. They achieve this by providing simple criteria that will serve as a sound basis for an unequivocal diagnosis of either a benign or a malignant melanocytic neoplasm. The reader will find Histological Diagnosis of Nevi and Melanoma to be an invaluable guide to correct diagnosis even in difficult or rare cases.Trade ReviewFrom the reviews of the second edition:“The book provides a logical, practical classification of melanocytic lesions, using the terminology most frequently used in dermatopathology laboratories. … This is a necessary book that provides useful information for both clinicians and pathologists. … This is a unique, comprehensive source of information for melanocytic lesion histopathology, and a likely must have for pathologists, dermatopathologists, and dermatologists.” (Susan M. Swetter, Doody’s Book Reviews, April, 2014)Table of ContentsCriteria for the Diagnosis of Benign Melanocytic Nevus.- Melanocytic Hyperplasia.- Melanotic Macules.- “Commonon” Nevus.- Congenital Nevus.- Junctional Anomalies in Congenital and Acquired Nevi in the First Year of Life.- Proliferative Nodules in Congenital Nevi.- Nevus Spilus.- Dermal Melanocytoses.- “Common “Blue Nevus.- “Cellular” Blue Nevus.- SPITZ Nevus.- Reed Nevus.- Deep Penetrating Nevus.- Dysplastic & Clarks’s Nevus.- Combinedin Nevus.- Nevi on Acral Skin.- Nevi on Genital Skin.- Nevi in the Oral Cavity.- Polypoid Nevus of Pregnancy and Milk Line Nevi.- Nevi OF the Conjunctiva.- Melanocytic Nevi Affected by inflammatory Skin Dideases.- Halo Nevus.- Recurrent and Persistent Nevus.- Traumatised Nevi.- Benign Melanocytoma.- Medicolegal Cases.- Criteria for the Diagnosis OF Malignant Melanoma.- Melanoma in situ.- Lentigo Maligna.- Superficial Spreading Pattern of Melanoma.- Nodular Pattern of Melanoma.- Melanoma with Spindle Cell.- Nevoid Melanoma.- Spitzoid Melanoma.- Desmoplastic Melanoma.- Neurotropic Melanoma.- Melanoma with Neural Differentiaton.- Myxoid Melanoma.- Melanoma with Features of Blue Nevus.- Animal Type Melanoma.- Melanoma on Blue Nevus.- Unusual and Bizarre forms of Melanoma.- Melanoma on Nevus.- Melanoma on Palms, Soles and Subungual Bed.- Melanoma on Genital Skin.- Melanoma on Oral Cavity.- Melanoma on Conjunctiva.- Recurrent and Persistent Melanoma.- Regressing and Regressed Melanoma.- Cutaneous Metastatic Melanoma.- Malignant Melanocytoma.- Medicolegal Cases.- Molecular Biology in the Diagnosis of Nevi and Melanoma.- Histological Prognostic Factors.
£237.49
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG The Transcervical Approach in Thoracic Surgery
Book SynopsisUse of the transcervical approach in thoracic surgery has advanced significantly during the past 60 years, owing primarily to advances in technology. Nevertheless, the possibilities of this approach have never been compiled in a systematic way. This book aims to rectify the situation by describing, in a structured way, all the thoracic procedures that can be performed using the transcervical approach. Indications and contraindications, surgical techniques, complications, and results are all covered, based on the authors’ experience and published reports. The contents encompass diverse surgical endoscopic procedures for diagnosis and staging, use of the transcervical approach for surgery to the thymus and mediastinum, lungs and bronchi, trachea and esophagus and miscellaneous items including the role of robotic surgery.Trade ReviewFrom the book reviews:“This book offers expert instruction on thoracic surgery through a cervical approach, covering current applications thoroughly and discussing future uses. … The book is written for practitioners and trainees in thoracic surgery. … This is a very useful book for practitioners of thoracic surgery interested in performing procedures through a cervical incision. It offers a detailed discussion of a topic often only covered in a textbook chapter. It will be a good addition to any reading on thoracic surgery.” (Michael Bates, Doody's Book Reviews, December, 2014)Table of ContentsDIAGNOSTIC AND STAGING SURGICAL ENDOSCOPIES.- Mediastinoscopy.- Extended Cervical Mediastinoscopy.- Remediastinoscopy.- Mediastino-Thoracoscopy.- Cervical Incision Thoracic Endoscopic Surgery (CITES).- Mediastinal Ultrasonography (MUS) as a Surgical Adjuvant In Lung Cancer Staging.- Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA).- Transcervical Extended Mediastinal Lymphadenectomy (TEMLA): The Standard Procedure And Its Variations.- THYMUS AND MEDIASTINUM.- Thymectomy Through Cervicotomy.- Transcervical Extended Thymectomy With Bilateral Opening Of The Mediastinal Pleura.- Transcervical Thymectomy With Bilateral Video-Assisted Thoracoscopic Surgery (VATS).- Rethymectomy.- Transcervical Resection Of Mediastinal Metastatic Nodes And Mediastinal Tumors.- Miscellaneous Indications: Mediastinitis, Cysts, Etc.- LUNGS AND BRONCHI.- Lobectomy.- Closure Of Postpneumonectomy Bronchopleural Fistula.- Closure Of The Main Bronchus Prior To The Definitive Pneumonectomy.- TRACHEA AND OESOPHAGUS.- Tracheal Resection.- Oesophageal Procedures.- MISCELLANY.- Thoracic Outlet Syndrome –Supraclavicular Approach.- Robotics.
£80.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG p53 Suppressor Gene
Book SynopsisThis book is about the p53 gene, one of the most frequently mutated or deleted genes in human cancers. The frequent occurrence of inactivated p53 implicates this gene product in the genesis of many human cancers. The p53 gene can suppress the growth of cancer cells and the transformation process by oncogenes. The p53 protein is a transcription factor that can repress or activate promoters containing one of three p53 DNA-binding motifs. The activity of p53 is regulated by phosphorylation and other transcription factors. Replacement of the p53 function or restoration of the p53 biochemical pathway is a focus of gene therapy.Table of Contents1. The Role of p53 in Cancer.- 2. Gene Structure.- 3. Wild-Type versus Mutant p53.- 4. Biophysical and Biochemical Properties of the p53 Protein.- 5. Regulation and Modulation of the Function of p53.- 6. Potential Clinical Significance of the p53 Tumor Suppressor Gene in Cancer Patients.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Onkologie Basiswissen
Book SynopsisDieses Werk legt eine solide und fundierte onkologische Wissensbasis; es zeigt auf, warum Menschen an Krebs erkranken, wie der Körper auf Krebs reagiert und welche Präventions- und Behandlungsmöglichkeiten es für verschiedene Krebserkrankungen gibt. Entstehungsmechanismen, Diagnose- und Therapieoptionen inklusive moderner Entwicklungen in der personalisierten Medizin und der regionalen Chemotherapie werden vorgestellt und diskutiert.Das Buch richtet sich an angehende Ärzte aller Fachrichtungen sowie Angehörige von Gesundheitsberufen, die sich grundlegend mit der Onkologie beschäftigen wollen. Es bietet eine wertvolle Grundlage für das Aneignen tiefer gehenden Fachwissens.Trade Review“... eine leicht verständliche und allgemeine Einführung in das Thema Krebs für Studierende der Medizin und Medizinwissenschaft, für onkologische Pflegekräfte und Angehörige anderer Gesundheitsberufe weltweit ...” (Gyne, Jg. 5, Heft 38, 2017)Table of ContentsTeil I – Das Krebsproblem: Was ist eine maligne Erkrankung?.-Epidemiologie.- Konkrete Maßnahmen zur Krebsprävention.- Teil II – Allgemeine Merkmale der Manifestation einer Krebserkrankung und deren Behandlung: Symptome von Krebs: Lokal- und Allgemeinsymptome.- Anzeichen von Krebs: lokale und allgemeine Krankheitszeichen.- Klinische Pathologie von Krebserkrankungen.- Untersuchungsmethoden zur Krebserkennung.- Krebstherapie.- Beziehung zwischen Patienten, Ärzten und Behandlungsteam.- Teil III – Die häufigsten Krebserkrankungen: Hautkrebs.- Lungenkrebs (Bronchialkarzinom).- Brustkrebs (Mammakarzinom).- Krebs des Verdauungstraktes.- Krebs im Kopf-Hals-Bereich.- Krebs der weiblichen Geschlechtsorgane.- Krebs der männlichen Geschlechtsorgane.- Blasen- und Nierenkrebs.- Krebs des Gehirns und des Nervensystems.- Leukämien und Lymphome.- Weichteilsarkome.- Maligne Knochen- und Knorpeltumoren.- Metastasen (Sekundärtumoren).- Teil IV – Fortschritte: Methoden und Evidenz des Fortschritts.- Personalisierte Medizin.- Perspektiven.- Weiterführende Literatur.- Glossar.- Weltweite Inzidenz der häufigeren Krebsarten.- Sachverzeichnis.
£52.24
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Yoga Zurück ins Leben: Wie Yoga bei Krebs helfen
Book SynopsisDie Autorin erkrankte in ihrem Leben zwei Mal an Leukämie. Yoga half ihr bei der Bewältigung der lebensbedrohenden Krankheit und auf ihrem Weg zurück in ein erfülltes kraftvolles Leben. Ihre Erfahrungen gepaart mit ihrem Wissen als ganzheitliche Ärztin mit eigener Yogapraxis gibt sie nun in diesem Buch weiter. Einfach und anschaulich beschreibt sie welche Strategien zur Bewältigung der bei Krebs häufig auftretenden körperlichen und mentalen Lebenskrise helfen können und wie sich die Geisteshaltung und Lebensführung durch Yoga positiv auf die Krankheit auswirkt. Herzstück des Buches sind die Yoga-Übungsanleitungen in Wort und Bild. In einfachen, gut nachvollziehbaren Anleitungen stellt sie Übungen vor, ihre therapeutische Wirkung und Abwandlungen für mögliche körperliche Einschränkungen. Aus Aufwärmübungen, Körperhaltungen (Asanas) und Atemübungen (Pranayama) kann ein individuelles, vollständiges Übungsprogramm zusammengestellt werden. Das Buch richtet sich an Betroffene, sowie an Yogalehrer, Trainer und Physiotherapeuten, aber auch an Ärzte und Pflegekräfte in der Onkologie.Table of Contents1. Wie die Diagnose Krebs Menschen verändert.- 2. Zurück ins Leben - gibt es ein normales Leben danach?.- 3. Onkorehabilitation mit Bewegung.- 4. Yoga für "Surviver" - Erfolge von Yogatherapie in klinischen Studien.- 5. Yoga - indische Gymnastik?.- 6. Yoga Übungsanleitungen. 7.- Den Yogaweg leben mit Ayurveda.- 8. Serviceteil.
£26.59